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Engineering a complex tissue that exceeds 100-200 µm requires a vascular 
connection. Methods to enhance vascularization include the delivery of angiogenic 
factors, and the use of scaffolds that encourage vascular ingrowth. However, these 
techniques rely on the host to vascularize the construct upon implantation, which is often 
too slow to provide nutrients to the entire construct. Hence, recent research has focused 
on creating de novo vascular networks prior to implantation. Such technologies would 
enable faster anastomosis with the host vascular system, as well as fully perfused 
constructs that can increase cell viability. Many techniques have been investigated to 
create de novo vascular networks with varying levels of success. Our approach was to 
utilize native vascular extracellular matrix (ECM) obtained from decellularizing highly 
vascularized tissue as a substrate for re-endothelialization and thus to create a three-
dimensional vascular bed for ultimate use with various implant and tissue engineering 
applications. We have demonstrated a method of chemical decellularization that 
effectively removes cellular material while leaving behind an organized patent vascular 
network down to the capillary scale. Standard histological methods, DNA quantification, 
as well as vascular corrosion casting demonstrated this efficacy. Subsequent 
subcutaneous implantation then explantation of the scaffold at 7 and 28 days was used to 
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assess the immunogenicity of the graft by analyzing the presence of immune cells. This 
scaffold was then re-endothelialized with human dermal microvascular endothelial cells 
(HDMECs) and conditioned with peristaltic flow for 60 hours to help improve vascular 
patency. Cellular distribution was determined qualitatively by first incubating the 
HDMECs with gold nanotracers, then imaging their presence upon implantation through 
ultrasound-guided photoacoustic (US/PA) imaging. Following the culture process, the 
scaffolds were analyzed for vascular patency through vascular corrosion casting, and 
cellular phenotype through histological methods—demonstrating a decrease in vascular 
damage. The re-endothelialized scaffolds were then assessed for functional vascular 
performance by perfusing whole blood through them. Results demonstrated better blood 
clearance in re-endothelialized scaffolds compared to scaffolds without cells. These 
results point to the ability of the optimized acellular (OA) scaffold to be used in future 
experiments focused on vascular and tissue engineering. 
 vii 
Table of Contents 
List of Tables ...........................................................................................................x 
List of Figures ........................................................................................................ xi 
Chapter 1:  Introduction ...........................................................................................1 
Chapter 2:  Background information on tissue engineering thick constructs—the 
importance of a working vasculature ..............................................................4 
2.1 Angiogenic factors and permissive scaffolds for vascularization.............8 
2.2 Engineering a vascular architecture ..........................................................9 
 2.2.1 Microfabrication .........................................................................11 
 2.2.2 Prevascularized techniques .........................................................12 
2.3 Role of ECM in Vascularization .............................................................18 
 2.3.1 Decellularization methods ..........................................................20 
2.4 Cell lineages in vascularization ..............................................................24 
 2.4.1 Mesenchymal stem cells .............................................................25 
 2.4.2 Endothelial progenitor cells ........................................................26 
2.5 Fluid shear stress on cells .......................................................................26 
2.6 Analysis of vascular networks ................................................................28 
 2.6.1 Vascular casts used to elucidate vascular structure ....................28 
2.7 Reseach goals ..........................................................................................30 
Chapter 3:  Development and characterization of a decellularized vascular scaffold
.......................................................................................................................33 
3.1 Introduction .............................................................................................33 
3.2 Research design and methods .................................................................33 
 3.2.1 Selecting the optimal tissue source .............................................33 
 3.2.2 Decellularization selection ..........................................................36 
 3.2.3 Histological characterization of decellularized lung tissue ........38 
 3.2.4 DNA Quantification ....................................................................39 
 3.2.5 Vascular casting ..........................................................................40 
 viii 
 3.2.6 Testing immunogenicity of an optimized acellular vascular scaffold
..............................................................................................................41 
3.3 Results .....................................................................................................42 
 3.3.1 Optimized acellular decellularization .........................................43 
 3.3.2 Optimized acellular process effective at removing cellular material 
while preserving ECM content ............................................................47 
 3.3.3 DNA quantification confirms removal of nucleic material following 
decellularization ...................................................................................49 
 3.3.4 Vascular corrosion casting ..........................................................55 
 3.3.5 Subcutaneous implantation of OA scaffolds in vivo  present  normal 
immunogenic response.........................................................................55 
3.4 Conclusions .............................................................................................65 
Chapter 4:  Re-endothelialization of a decellularized vascular scaffold ................66 
4.1 Introduction .............................................................................................66 
4.2 Research design and methods .................................................................66 
 4.2.1 Culture and incubation of endothelial cells with gold nanotracers .
..............................................................................................................66 
 4.2.2 Ultrasound-guided photoacoustic imaging of re-endothelialized 
scaffolds ...............................................................................................67 
 4.2.3 Re-endothelialization optimization in optimized acellular scaffolds
..............................................................................................................68 
 4.2.4 Pulsatile cell culture ....................................................................69 
 4.2.5 Vascular casting of re-endothelialized scaffolds ........................70 
 4.2.6 Whole-blood perfusion assay ......................................................70 
4.3 Results .....................................................................................................71 
 4.3.1 Endothelial cells cultured with gold nanotracers exhibit normal 
morphology and no cytotoxicity ..........................................................72 
 4.3.2 Optimized injection parameters enable uniform cellular distribution
..............................................................................................................72 
 4.3.3 Re-endothelialization of OA scaffolds with HDMECs improves 
vascular patency down to the capillary scale .......................................79 
 4.3.4 HDMEC re-endothelialized OA scaffolds clear perfused blood 
compared to barren OA scaffolds ........................................................88 
4.4 Conclusions .............................................................................................95 
 ix 
Chapter 5:  Discussion ...........................................................................................97 
5.1 Introduction .............................................................................................97 
5.2 Selecting vascular tissues ........................................................................97 
5.3 Optimized acellular decellularization of lung .........................................98 
5.4 Differences in decellularization techniques difficult to elucidate using 
standard histological analyses ..............................................................99 
5.5 Quantitative vacsular corrosion casting effectively distinguishes differences 
in vascular patency between different acellular scaffolds .................101 
5.6 OA processed scaffolds are immune tolerated......................................104 
5.7 Ultrasound guided photoacoustic imaging is an effective tool to display 
cellular distribution ............................................................................106 
 5.7.1 Cellular uptake of nanotracers does not alter cell fate ..............107 
 5.7.2 US/PA imaging effective at detecting cellular distribution in OA 
scaffolds .............................................................................................108 
5.8 Re-endothelialization and perfusion-culture with HDMECs improves 
vascular patency .................................................................................110 
 5.8.1 Perfusion set-up and shear calculations ....................................111 
 5.8.2 Vascular patency determination ................................................112 
5.9 Improved vascular patency improves cellular clearance of blood in 
decellularized scaffolds ......................................................................113 
Chapter 6:  Conclusions and future directions .....................................................117 
Appendix A:  Left lung isolation protocol ...........................................................123 
Appendix B:  Hematoxylin and eosin stianing ....................................................124 
Appendix C:  Vascular corrosion casting protocol ..............................................125 
Appendix D:  HPLC analysis ...............................................................................126 
Appendix E:  CD-31 stained explants ..................................................................135 




List of Tables 
Table 1: Extravasation Counts per mm2 for Different Decellularization Methods
...........................................................................................................58 
Table 2: Extravasation Counts per mm2 for Different Decellularization Methods 
and Re-endothelialization .................................................................91 
 xi 
List of Figures 
Figure 1: Diagram of chondrocyte transplantation in the right femoral condyle .
.............................................................................................................5 
Figure 2: Apligraft prior to clinical use ..............................................................6 
Figure 3: The structure of the porous poly(ether ester) block–copolymer scaffolds 
as imaged by electron microscopy ....................................................10 
Figure 4: Microfabricated vascular stuctures ...................................................13 
Figure 5: Photograph of a matrix encased in the isolation chamber before 
implantation ......................................................................................15 
Figure 6: Microsurgically created AV loop in the groin of the rat ...................16 
Figure 7: Prevascularization in vitro ................................................................17 
Figure 8: Schematic of EC ECM involvement following injury ......................19 
Figure 9: Optimized acellular protocol .............................................................22 
Figure 10: Perfusion SDS decellularization protocol .........................................23 
Figure 11: Mechanism of EPC-mediated postnatal neovascularization .............27 
Figure 12: Gradual shear stress affects HUVEC morphology ...........................29 
Figure 13: Images of acrylic corrosion casts of normal lamb pulmonary vasculature
...........................................................................................................31 
Figure 14: Isolated left lung lobe following heparinization, blanching, harvest, and 
isolation .............................................................................................35 
Figure 15: Perfusion-based decellularization using the PSDS protocol on isolated 
rat lung ..............................................................................................37 
Figure 16: Mercox injection in the pulmonary artery of decellularized lung tissue
...........................................................................................................40 
 xii 
Figure 17: H&E staining for optimized acellular decellularized lung segments of 
different widths .................................................................................44 
Figure 18: Initial decellularization of liver and lung tissue ................................45 
Figure 19: Increasing OA detergent incubation time improves decellularization46 
Figure 20: H&E staining following different decellularization methods on lung 
tissue .................................................................................................48 
Figure 21: CD-31 and laminin immunostaining following different decellularization 
methods on lung tissue ......................................................................50 
Figure 22: α-smooth muscle actin immunostaining following different 
decellularization methods on lung tissue ..........................................51 
Figure 23: Fibronectin and DAPI immunostaining following different 
decellularization methods on lung tissue ..........................................52 
Figure 24: Staining for DAPI reveals removal of nuclei following decellularization 
of lung tissue using different methods ..............................................53 
Figure 25: DNA concentration of fresh and decellularized lung tissue .............54 
Figure 26: VCCs of lungs following decellularization using different methods 56 
Figure 27: SEM images of VCC of lungs following decellularization using different 
methods .............................................................................................57 
Figure 28: Extravasation volume per mm
2
 by decell method ............................59 
Figure 29: Right flank of a rat opened following four weeks in vivo to reveal the 
subcutaneous OA  implant ................................................................61 
Figure 30: Isogeneic and allogeneic OA explants harvested one week following 
subcutaneous implantation ................................................................62 
Figure 31: Isogenic and allogenic OA explants harvested four weeks following 
subcutaneous implantation ................................................................63 
 xiii 
Figure 32: Number of ED1 positive cells per nuclei counted ............................64 
Figure 33: Effects of nanoparticle incubation on HDMEC morphology. ..........73 
Figure 34: Effects of nanoparticle incubation on HUVEC morphology ............74 
Figure 35: HDMEC MTS assay .........................................................................75 
Figure 36: HUVEC MTS assay ..........................................................................76 
Figure 37: Ultrasound-guided photoacoustic imaging of an optimized acellular 
scaffold ..............................................................................................77 
Figure 38: Nanoparticle injection into an OA scaffold ......................................78 
Figure 39: Single bolus injection of HUVECs into an OA scaffold ..................80 
Figure 40: Multiple injections of HUVECs into an OA scaffold .......................81 
Figure 41: Multiple injections of HDMECS into an OA scaffold......................82 
Figure 42: Histological analysis of re-endothelialized tissue .............................83 
Figure 43: Perfusion culture following HUVEC re-endothelialization ..............84 
Figure 44: Perfusion culture following HDMEC re-endothelialization .............85 
Figure 45: Perfusion culture following HDMEC re-endothelialization with 
improved US/PA processing .............................................................86 
Figure 46: VCCs of re-endothelialized OA scaffolds with HUVECs and HDMECs 
following perfusion culture for 60 hr ................................................87 
Figure 47: Comparison of large vessels in VCCs ..............................................89 
Figure 48: Photographs of re-endothelialized OA scaffolds ..............................90 
Figure 49: Re-endothelialized extravasational volume per mm
2
 .......................92 
Figure 50: Photographs of whole blood perfusion into OA decellularized scaffold
...........................................................................................................93 
Figure 51: OA scaffolds re-endothelialized with HDMECs help decrease leakage of 
whole blood .......................................................................................94 
 1 
Chapter 1: Introduction 
Tissue engineering techniques are attempting to alleviate problems experienced 
because of the shortage of organ donors, by creating functional alternatives for those in 
need.  To date, successful tissue engineered products have been limited in part because of 
poor nutrient delivery to cells within constructs that are more than several hundreds of 
microns thick—this is in part because they lack a vascular network.  Thus, improving the 
capabilities to achieve vascularization of tissue constructs has become one of the 
paramount topics in biomedical engineering. 
Current strategies to improve the vascularization of tissue constructs encompass 
the traditional tissue engineering focuses:  scaffolds, growth factors, and cells, in 
innumerous combinations.  Angiogenic factors have increased vascular growth into 
constructs—which have in turn been investigated to determine ideal properties for 
vascular ingrowth.  Countless cell lineages have also been evaluated for their efficacy as 
well.  As the field of vascular engineering has become more mature, research has begun 
to focus on ways to create working vascular networks in scaffolds in vitro, prior to their 
implantation in vivo.  This strategy aims to create networks that only require vascular 
ingrowth into the extremity of the scaffold in order to anastomose into the network and 
subsequently provide rapid nutrient delivery. 
We have created a thick tissue engineering scaffold that maintains the native 
architecture of a highly vascularized tissue down to the capillary scale.  This construct 
can be perfused with cells to ensure their even distribution throughout its entirety; it can 
be connected to peristaltic flow to condition cells within the vascular network; it also has 
the potential to be anastomosed into a vascular axis in the body, enabling rapid perfusion.  
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Such a construct could support cellular viability throughout its entirety, and become a 
potential candidate for organ replacement in future studies. 
This dissertation is divided into six chapters.  Chapter 2 provides background 
information regarding past research and successes in tissue engineering scaffolds, 
centered on improving vascularization of scaffolds.  A description of the potential 
benefits of tissue engineering scaffolds, scalability issues, and current solutions to 
scalability problems is first presented.  Next, an overview of decellularization techniques, 
and possible advantages over synthetic scaffolds are discussed, followed by a discussion 
of the important components of the extracellular matrix to vascular engineering.  Finally, 
an in depth look at cells used in vascular engineering is presented. 
Chapter 3 describes the development and characterization of an optimized 
decellularization method compared to other decellularization methods.  The experimental 
design and methods used throughout the creation and evaluation of the vascular 
optimized acellular (OA) scaffold, methods for characterizing tissue following 
decellularization, and implantation into animals for immunogenicity testing will be 
described.  The OA scaffold provided better preservation of vascular patency following 
decellularization compared to other decell methods, while still removing cellular and 
immunogenic material.  Differences between decell methods were not seen through 
normal histological methods, but were only visualized during VCC—supported through 
histological, vascular casting, and in vitro analyses. 
Chapter 4 presents the work necessary to re-endothelialize the vascular OA 
scaffold.  Different endothelial cell lineages were injected into the vascular axis of the 
vascular OA scaffold and assessed for initial distribution, retention following perfusion 
culture, and the subsequent vascular performance of the tissue—indicated with vascular 
corrosion casts, and propensity to hemorrhage following the injection of whole blood.  
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Optimizing the re-endothelialization enabled even distribution of cells as seen through 
US/PA imaging.  Subsequent VCC analysis demonstrated a recovery of vascular patency 
due to re-endothelialization.  The re-endothelialized OA scaffold also allowed for better 
clearing of whole-blood compared to barren scaffolds. 
Chapter 5 entertains a discussion of the results in Chapter 4.  The reasoning 
behind the selection of the decellularization protocol, as well as control groups is 
highlighted.  Animal selection and source material selection was also explained, both for 
the organ harvest, as well as the immunogenicity study.  A discussion of the components 
removed and preserved following the decellularization process is presented regarding 
their importance in vascular engineering.  The interpretation of vascular casts is also 
discussed, highlighting the importance of testing for functionality when performing 
decellularization.  Interpretation of US/PA imaging as a tool for tracking cellular 
distribution is also discussed.  Finally, the function recovery regarding vascular patency 
following re-endothelialization, and its importance in subsequent tissue engineering 
ventures is discussed. 
Chapter 6 is a summary of the work performed to complete this dissertation, as 
well as the future directions for this project—both as a substrate for tissue regeneration, 
as well as for use as a substrate to obtain a better understanding of biological 
phenomenon in a complex environment.  
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Chapter 2:  Background Information on Tissue Engineering Thick 
Constructs—the Importance of a Working Vasculature 
As the organ wait list continues to exceed the number of donors each year (over 
100,000 in need, under 15,000 donors) [1], the need for alternative therapies to 
transplantation, such as tissue engineered constructs, is becoming increasingly important. 
Yet, the most successful tissue engineered products have been either avascular structures 
(cartilage) or thin membranes (skin and bladder) (Figures 1, 2) [2-4]. Engineering more 
complex tissues, such as myocardium, bone, or skeletal muscle, requires a nutrient 
delivery system that matches the metabolic needs of the tissue [5]. Researchers have 
demonstrated that a vascular connection is necessary to maintain viability in tissues 
beyond 100-200 µm thick [6]. One of the limiting factors in creating a complex tissue 
construct is the rate of vascular ingrowth upon implantation. The spontaneous vascular 
growth in the human body is only several tenths of microns per day [7], far too slow to 
traverse constructs ranging in the hundreds of microns in a biologically-relevant time 
scale. This limited vascular ingrowth results in poor nutrient and oxygen delivery to the 
cells comprising the construct. Nutrient delivery is a critical component for any type of 
organ transplantation [8], and the failure to address the metabolic needs of cells often 
leads to the formation of necrotic cores in engineered substitutes [9-13]. A hindered 
oxygen supply is not only responsible for cell death and the failure of most grafts [14], 
but can also increase vascular endothelial growth factor (VEGF) and mRNA 
transcription, which can have detrimental effects on tissues by producing leaky, abnormal 
vascular structures [15, 16]. To overcome these potential problems, researchers have 
attempted to create de novo vascular constructs prior to implantation. However, many of 
these techniques fail to create mature, three-dimensional networks. Another concern with 
current strategies has been keeping cells viable in the construct as the vascular network is  
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Figure 1. Diagram of chondrocyte transplantation in the right femoral condyle.  
(Brittberg, M., et al. New England Journal of Medicine, 1994). 
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Figure 2. Apligraft prior to clinical use. Apligraft is a bilayered skin simulant 
constructed of type-I bovine collagen (extracted from bovine tendons and 
subsequently purified) and live allogeneic human fibroblasts and keratinocytes 
(isolated from human foreskin). Apligraft is packaged in a clear plastic carrier 
tray assembly consisting of four pieces—the tray, a tray insert with porous 
membrane, a gel tissue-support medium and the tray lid.  (Kirsner, R.S., et al. 
Trends in Biotechnology, 1998). 
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being synthesized [17]. We aim to create a construct with a functional vascular network 
that can be microsurgically connected to the host vasculature, which will ensure rapid 
anastomosis and the likely survival of cells within the construct. 
Many clinically available tissue constructs and tissue engineered products are 
derived from natural tissues, including the porcine small intestinal submucosal (SIS)-
based acellular products from Cook Biotech, AlloDerm decellularized human dermis 
from LifeCell, and AxoGen’s Avance decellularized human nerve graft. These are 
examples of intact tissues that have been decellularized and used clinically as growth-
promoting scaffolds. In addition, other products are derived from natural tissue 
components, rather than intact tissues, including the Apligraft skin substitute from 
Organogenesis, Inc., which consists of natural collagen combined with neonatal human 
cells (Figure 2), and Ace Surgical Supply, Inc.’s Osteocel allograft “powdered” bone 
matrix, which retains native immune-privileged mesenchymal stem cells (MSCs). 
Despite these exciting clinical advances, less academic research is being devoted to 
investigate either how to modify natural materials to make them more effective, or to 
pursue new avenues in which these materials can be used. Instead, most academic 
research is focused on complex synthetic materials and nanocomposites, although the 
clinical viability of these approaches may be farther from realization. We use 
decellularized ECM as a construct upon which endothelial cell lineages will expand and 
form a biologically relevant vascular network. A few other researchers have investigated 
the ability to re-endothelialize an acellular vascular scaffold [18-20]; however, these 
researchers used a tissue source that was only 200 µm thick. Furthermore, the construct 
formed was not evaluated for immunogenicity or long-term thrombogenicity. By using a 
decellularized 3D native vascular scaffold as a framework for endothelial expansion, we 
combat the issues that have plagued the success of tissue constructs. Furthermore, using 
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acellular scaffolds provides a potentially unlimited source of starting material from 
cadavers or xenogeneic sources.  
In addition to natural acellular tissues, which will facilitate future translation, we 
also propose to use HDMECs to re-endothelialize the remaining vascular ECM network.  
The controlled injection into only the vascular space enabled the patency of the vascular 
network to improve versus scaffolds without cells. This system has the potential for use 
as an ex vivo culture system to test more clinically relevant cell models in subsequent 
studies. 
2.1 ANGIOGENIC FACTORS AND PERMISSIVE SCAFFOLDS FOR VASCULARIZATION 
The use of growth factors is one area of research that has attempted to promote 
vascularization. The most well-known angiogenic growth factor is vascular endothelial 
growth factor (VEGF). In addition to VEGF, other growth factors which promote new 
vessel formation include placental growth factor (PIGF), and basic fibroblast growth 
factor (bFGF) [21]. However, use of these growth factors creates vessels which are 
erratic, hemorrhagic, and leaky [16, 22]. To correct these drawbacks, researchers have 
investigated ways to promote vessel stability. Most attempts involve the use of growth 
factors that recruit pericytes or smooth muscle cells. For example, transforming growth 
factor beta (TGF-β) forms ECM that causes interactions with endothelial cells (ECs) and 
mural cells and more stable vessels [21, 23]. Platelet derived growth factor (PDGF) and 
angiopoietins (Ang1/2) have also been used to stabilize vessels [24-26]. In addition to 
growth factors that directly influence vessel stabilization, indirect therapies, such as sonic 
hedgehog (SHH), can lead to VEGF and Ang1/2 expression and the formation of stable 
vessels. Although these methods can increase vascularization and the rate of vascular 
ingrowth when combined with a tissue construct, they still require the host vascular 
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system to initiate vascularization on the exterior of the tissue construct, leading to 
nutrient deficiency and hypoxia in the center of the construct [17]. 
Closely coupled to the use of angiogenic factors are scaffolds designed to permit 
vascular ingrowth and physical support. Tissue engineered scaffolds must be designed to 
provide cells with a substrate on which they can proliferate and differentiate. In addition 
to supporting the tissue-specific cells that the construct has been seeded with, the scaffold 
must allow for incorporation into the site that it is implanted. Angiogenic factors are 
capable of providing cues that promote increased levels of angiogenesis and are often 
coupled to scaffolds as a therapeutic combination [27]; however, scaffolds need to be 
optimized to allow for easy vascular ingrowth. Researchers have demonstrated that pores 
that are greater than 250 µm allow for faster ingrowth (Figure 3) [28]. Additionally, pore 
connectivity has been shown to be an important factor in facilitating vascular ingrowth 
[29, 30]. Although scaffolds help direct vascularization of a tissue construct, this 
organization is still erratic and too slow to prevent central necrosis. Bioreactors that help 
perfuse constructs with cells have been used to prevent necrosis in the middle of the 
construct [31]. However, bioreactor use still does not address concerns regarding forming 
a functional vasculature that can be anastomosed upon implantation [32]. As such, 
research has been dedicated to creating systems that give rise to a functional and well 
defined vascular architecture. 
2.2 ENGINEERING A VASCULAR ARCHITECTURE 
With the shortcomings relying on the host to vascularize a tissue engineered 
construct, research has focused on creating de novo vascular networks prior to 
implantation. Such technologies would enable faster anastomosis with the host vascular 
system, as well as fully perfused constructs that can increase cell viability. Additionally,  
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Figure 3. The structure of the porous poly(ether ester) block–copolymer scaffolds as imaged by electron microscopy. Three different types 
of scaffolds (A: 20–75 μm; B: 75–212 μm, C: 250–300 μm) were implanted into the chamber to measure neovascularization. (Druecke, D., 
et al. Journal of Biomedical Materials Research Part A, 2004). 
  
 11 
tissue engineered constructs must mimic the shape of a vascularized network down to 
capillary meshes and support fluid flow. Ott et al. have demonstrated that ECs cultured in 
the presence of fluid shear stress have better retention in vascular constructs once 
implanted into patients [33]. When subjected to fluid shear stress ECs change 
morphology and align their actin filaments in the direction of the applied stress [34, 35]. 
Shear stress not only directs morphological change but also affects gene expression in 
ECs, upregulating prostacyclin secretion [36]. Technologies that attempt to recreate 
biologically relevant geometries, as well as functional vessels can be divided into 
microfabricated and prevascularized techniques. 
2.2.1 Microfabrication 
Microfabrication has been used in a number of biological applications to obtain 
well defined architectures that suit their function. Soft lithography can be used to create 
microfluidic devices that have since been applied to biological systems [37, 38]. 
Endothelial cells have been successfully added to the surface of microchannels in 
vascularization engineering applications [39, 40]. Such devices are ideal for vascular 
engineering as they can achieve capillary dimensions and can sustain fluid flow. 
However, these early attempts at a vascular tissue engineered construct suffered from 
problems regarding the substrate used, and the channel geometry created. Most systems 
relied on poly(dimethylsiloxane) PDMS substrates, a polymer that yields unpredictable 
interactions with biological components [41]. Since then, alternative biodegradable 
substrates including poly(lactic co-glycolic acid) (PLGA) [42] and poly(glycerol 
sebacate) (PGS) [43] have been implemented in soft lithographical systems. However, 
although these polymers have better known cellular interactions, their mechanical 
properties and degradation profiles are not well understood in microfluidic systems [44]. 
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Another issue with early microfluidic systems was the rigid geometry of the channels 
produced [41]. PDMS microchannels typically have rectangular cross-sections and sharp 
furcations which lead to problems in cell seeding [45], and shear dynamics [46]. 
Recently, Borenstein et al. attempted to address these geometrical considerations by 
constructing a microfluidic system that has rounded cross-sections and smooth furcation 
transitions (Figure 4) [41]. Although this system has ideal geometries for vascular 
reconstruction, the PDMS substrate used still inhibits the practicality of this method. 
Another problem with the methods discussed so far is their inability to be translated into 
three-dimensional (3D) constructs. Most systems are simply thin films that contain 
microchannels. To achieve 3D constructs, researchers have resorted to stacking thin films 
together or rolling them into 3D tubes [40]. Other methods like 3D printing have been 
utilized successfully in tissue engineering to create 3D constructs [47, 48]; however, 
issues regarding the pore size and mechanical properties of the substrates used in this 
method detract from the efficacy of this technology [49]. 
2.2.2 Prevascularized Techniques 
Alternative methods to create a fully perfused construct that can be rapidly 
anastomosed have involved prevascularization. Although this technique does not offer 
the precision of microfabricated techniques, by allowing natural vessel formation to occur 
prior to implantation, a functional vasculature can be created in comparatively thick 
constructs. In general, prevascularized techniques rely on de novo vascularization prior to 
implantation into the region of interest. The two main methods have been implemented to 
achieve this are divided into in vivo and in vitro techniques. 
Prevascularization in vivo utilizes the host vascular system to perfuse constructs 
in an inert region prior to transplantation to the region of interest. This technique is a  
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Figure 4. Microfabricated vascular structures.  (a) SEM image of a Cu electroplated mold on silicon 
wafer showing four levels of smooth vessel bifurcations. (b) Higher magnification SEM image 
showing inverse half cylindrical geometry of the electroplated mold to be used to emboss half-




modification of a surgical procedure developed in the 1960s by Buncke and McLean 
[14]. These researchers wrapped a vascular transplant around a tissue implant to 
accelerate anastomosis. Since that time, the use of an arteriovenous (AV) loop to perfuse 
tissue implants in vivo has been successfully demonstrated [50]. This technique has 
subsequently been implemented with a variety of constructs to promote vascularization 
and regeneration of various tissues [51-54] (Figures 5, 6) and large animal models [55]. 
In this method, the AV loop is either wrapped around the tissue construct, or implanted 
directly into the graft. This allows the host vascular system to vascularize the construct 
for several weeks. After this vascularization period, the construct is harvested along with 
the vascular axis (the major artery and vein vascularizing the tissue) and microsurgically 
connected to the host vascular system in the defect site. This method allows for rapid 
anastomosis to occur throughout the construct in a fully functional system. Despite these 
benefits, the necessity for multiple surgeries and the loss of a functional vascular axis are 
significant drawbacks. Additionally, some cell death, and unwanted tissue formation in 
the graft during the vascularization period in vivo is likely to occur. 
In contrast, in vitro prevascularization is a co-culture method used to develop 
lumen in tissue constructs prior to implantation. Endothelial cells are co-cultured with 
mural cells and tissue-specific cell lineages to achieve an implantable construct. Once 
implanted, these constructs can anastomose with the host after only four days [56]. Skin 
[57], muscle [58], cardiac muscle [59], and bone [60] have all been therapeutically tested 
using this method with differing levels of success (Figure 7). One reason for the 
dissonance of results, even in the same tissue type is the variability of the culture process 
[17]. The nature of co-culturing cells makes optimization for each cell line used nearly 




Figure 5.  Photograph of a matrix encased in the isolation chamber before 
implantation. The arteriovenous loop is simulated using plastic tubing (Left).  
Vascular corrosion cast of a construct from group A (8 weeks after 
implantation). Blood vessels of different sizes originate from the circular 
arteriovenous loop. A higher vascular density is observed in the venous region 
of the loop than in the vein graft or the arterial region. Arrows indicate the site 
of the anastomosis between the vein graft and the vascular pedicle. A¼ artery, 
V¼vein.  (Kneser, et al. Tissue Eng, 2006). 
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Figure 6.  Microsurgically created AV loop in the groin of the rat, 
consisting of femoral artery (Left) (black arrow), interpositional vein 
graft (arrow head) and femoral vein (white arrow).  (Right) Teflon 
chamber (inner diameter 10 mm, height 6 mm) filled with fibrin, 
containing the AV loop  femoral artery = black arrow, 
interpositional vein graft = arrow head and femoral vein = white 
arrow) wrapped around the fixing stacks (arrow head).  (Bach, et al. 
J Cell Mol Med, 2006). 
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Figure 7.  Prevascularization in vitro. Images of Calcein-AM-stained 
HDMEC under angiogenic-stimulating of HDMEC and HDMEC in 
coculture with primary human osteoblasts on porous hydroxyapatite 
(left), porous calcium phosphate (right).  Confocal images of qdot-
labeled HDMEC in coculture with HOS stained with endothelial cell-
specific PECAM-1 (green) and nuclei stained with DAPI (blue) 42 
days after addition to the respective biomaterials.  (Unger, et al. 
Biomaterials, 2007). 
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that robust lumina are still forming. Furthermore, although these constructs are fully 
penetrated with de novo lumen structures, the lumina formed might not be patent or 
interconnected with each other, causing failure of the construct once implanted. An 
alternative prevascularization technique using decellularized omentum as a substrate for 
re-endothelialization has been investigated [20]. The ECM of the vascular axis was 
seeded with EPCs in a perfusion based culture system [19] and demonstrated vascular 
patency for one week following implantation [18]. However, the characterization of the 
vascular ECM following decellularization as well as immunogenicity of the construct 
need to be determined before this technology can be implemented in vivo. 
2.3 ROLE OF ECM IN VASCULARIZATION 
Endothelial ECM consists primarily of collagen type I, fibrin (or fibronectin) and 
a laminin rich basal membrane [61]. These proteins have distinct functions in regard to 
proliferation and migration, and stabilization during development and vascular healing. 
EC survival and proliferation are highly dependent upon adhesion to collagen I and fibrin 
[61]. Additionally, collagen and fibrin support chemotactic migration, and migration 
independent of chemokines [62]. Following injury, the basal membrane is first degraded, 
ECs then proliferate and migrate within tissues containing interstitial collagen (Figure 8) 
[63, 64]. Interactions with collagen cause a spindle-like morphology that will eventually 
reorganize into lumina over time [65, 66]. The transduction of mechanical forces through 
the ECM allows ECs to establish tension-based guidance pathways, leading to 
interconnected cords. This process can be conducted over long distances between cells, 
rendering cell-cell contact unnecessary [66]. Lumina then appropriate ECs from the 
interstitial matrix through the reestablishment of a basal lamina and form mature vascular 
structures [61]. Angiogenesis can be driven by chemical cues; however, ECM based  
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Figure 8.  Schematic of EC ECM involvement following injury.  In this schematic diagram, collagen 
type I, but not laminin-1, activates Src and Rho and suppresses Rac and PKA through β1 integrins. This 
results in induction of actin stress fibers, disruption of VE-cadherin, and formation of precapillary cords. 
In contrast, laminin-1 induces Rac and PKA and suppresses Rho and, therefore, does not provoke 
morphogenesis (top). These marked distinctions in signaling by collagen type I (“fire”) and laminin-1 
(“ice”) suggest a mechanism through which degradation of basement membrane and exposure of 
activated and proliferating ECs to collagen type I initiates morphogenesis of new capillary sprouts 
(bottom).  (Davis and Senger, Circ. Res., 2005). 
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mechanochemical control can dominate these cues based on its ability to control cell fate 
[67]. This characteristic has been demonstrated through prevascularized methods during 
which ECs were able to successfully organize a vascular construct independently from 
angiogenic factors [57, 58]. Another important function of the ECM is to sequester cells. 
Research has demonstrated that the conformation and orientation of fibronectin are key 
components in EC cell adhesion [68]. This important finding, intimates at the importance 
of being biomimetic not only in biochemical composition, but also in spatial architecture. 
Overall, the ability of endothelial ECM to direct EC fate makes scaffold composition a 
significant characteristic to define in a vascular construct. 
2.3.1 Decellularization Methods 
One tissue engineering method that exploits the biochemical and mechanical 
properties, as well as architecture of native ECM is decellularization. Generally 
decellularization methods aim to remove the cellular components from harvested tissue, 
including surface markers, while leaving the ECM proteins intact. This results in a 
biomimetic construct composed of a variety of ECM components that synergistically 
provide an ideal environment for cellular homeostasis that is devoid of immunogenic 
markers. In addition to immunogenicity, research has demonstrated increased 
calcification due to cellular components in vascular constructs [69], making removal of 
these components paramount to long-term success. A wide number of techniques, 
including thermal, chemical, and enzymatic, have been used to decellularize a variety of 
tissues for regeneration in muscle [70, 71], vasculature [69], nerve [72-75], cardiac 
muscle [76], and bladder [2, 20]. Although different processes have been used to 
decellularize tissue, each has its own caveats which dictate their efficacy. This behavior 
has been demonstrated through decellularized nerve constructs for peripheral nerve 
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injury. Thermal decellularization can effectively remove cells from tissue but fails to 
remove cellular debris that can still elicit an immune response and delay regeneration. 
Chemical decellularization on the other hand can effectively remove cellular components 
from the substrate, but can damage the ECM such that regeneration is hindered. To 
compensate for these shortcomings, research conducted previously in our lab has 
demonstrated that an optimized acellular (OA) protocol can be implemented to 
effectively remove cellular components while preserving the 10 µm diameter basal 
laminae (Figure 9) [73, 74]. Recently researchers have utilized a perfusion based method 
of decellularization to expedite cellular removal (Figure 10) [76]. Although this method 
was able to rapidly clear cellular components from rat heart tissue, the patency of the 
remaining lumen was not evaluated. 
The use of decellularized constructs in vascular engineering has largely focused 
on the formation of large vessels as substrates for bypass grafts [69]. Researchers first 
decellularize vascular grafts using detergent or enzymatic processes then re-
endothelialize the tunica intima [69]. Such methods have been able to create grafts that 
stay patent and completely re-endothelialize without calcification, thrombogenic, or 
immunogenic complications for up to 90 days [77, 78]. Decellularized constructs have 
also been used to differentiate progenitor cells into endothelial lineages. Kaushal et al. 
used EPCs to successfully re-seed porcine iliac vessels into patent grafts [79]. Lozito et 
al. have used ECM from a decellularized EC monolayer to differentiate MSCs toward EC 
lineages [80, 81]. Thus far, only Schultheiss et al. have applied the use of decellularized 
tissues for capillary vasculogenesis, utilizing a prevascularization model [18-20]. These 
researchers used bladder, then small intestine submucosa (SIS) ECM as a substrate for re-









1. Wash in ddH2O 
for 7 hrs 
2. Wash in SB-10 
solution for 15 hrs 
3. Rinse 1 X 15 
min in 100 mM 
Na/ 50 mM PBS 
4. Wash in Triton 
X-200/ SB-16 
solution for 24 hrs 
5. Rinse 3 X 15 
min in 100 mM 
Na/ 50 mM PBS 
6. Wash in SB-10 
solution for 7 hrs 
7. Rinse 1 X 15 
min in 100 mM 
Na/ 50 mM PBS 
8. Wash in Triton 
X-200/ SB-16 
solution for 15 hrs 
9. Rinse 3 X 15 
min in 50 mM Na/ 
10 mM PBS 
Figure 9.  Optimized acellular protocol.  Removal of Schwann cells was evaluated by staining 
tissue cross-sections for S-100 protein. The fluorescence in (a) fresh nerve tissue was 
considerably more intense than in nerve treated by (b) the optimized protocol.  (Hudson, Tissue 
Engineering, 2004).  The optimized acellular method utilized both anionic and amphoteric 




perfusion (10 µM 
adenosine) for 15 
mins 
2. 1% SDS for 12 
hours 
3. Deionized water 
for 15 mins 
4. 1% Triton X-100 
for 30 mins 
5. PBS for 124 hours 
Figure 10.  Perfusion SDS decellularization protocol.  Photographs of cadaveric rat hearts mounted on a 
Langendorff apparatus. Ao, aorta; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right 
ventricle. Retrograde perfusion of cadaveric rat heart using SDS over 12 h.  The heart becomes more 
translucent as cellular material is washed out from the right ventricle, then the atria and finally the left 
ventricle.  H&E staining of thin section of SDS-treated heart showing no intact cells or nuclei. Scale bar, 
200 m.  SDS Protocol maintains large vasculature conduits (black asterisks).  (Ott et al., Nature, 2008).  
The SDS protocol utilizes both anionic and non-ionic detergents in a perfusion-based processing cycle. 
Non-ionic Detergent 
Anionic Detergent 
Sodium dodecyl sulfate (SDS) 
Triton X-100 
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endothelialization can be established in this method, the potential for thrombogenesis and 
immunogenesis have yet to be thoroughly evaluated. Thrombogenicity is a particularly 
poignant concern considering historical problems in microvascular patency in SIS grafts 
[82]. Additionally, the SIS construct is only 200 µm thick and better suited as a patch, or 
thin membrane replacement compared to a large tissue construct [19]. 
2.4 CELL LINEAGES USED IN VASCULARIZATION 
Each vascular engineering method discussed thus far utilizes cells to promote 
vascularization and tissue regeneration.  By dictating cellular behavior, researchers are 
able to help coordinate events that ultimately lead to enhanced tissue regeneration.  
However, the factors that mediate cellular behavior in a particular therapy need to be 
optimized for each cell line used.  Systems that implement co-culture methods to help 
stabilize vascular systems further complicate matters, as culture conditions need to be 
ideal for each cell line used.  Different types of endothelial lineages along with 
endothelial progenitor lineages and stem cell lineage have been used to promote 
vascularization [14, 83, 84].  Problems with isolation and cellular expansion of adult cell 
lines detract from the feasibility of implementing these cell lines in a clinical setting.  
Clinical cell lines need to be easily isolated and rapidly expanded, and then perform 
physiological roles in order to be of benefit to the donor.  With these considerations in 
mind, researchers have started to evaluate the use of MSCs and EPCs in vascular 
therapies.  However, further complications arise when using MSCs and EPCs relating to 
their potential capacity for unwanted differentiation.  Thus, rigorous testing must be 
performed to ensure the benefits of these cells are realized without this potential for 
detrimental results.  From a preliminary standpoint, using well-defined, adult endothelial 
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cells is still advantageous, enabling the potential starting point for future use of 
progenitor lineages. 
2.4.1 Mesenchymal Stem Cells 
Stem cells present themselves as an ideal tool for tissue reconstruction based on 
their abilities to either self-renew or differentiate.  Increased levels of telomerase in stem 
cells means their proliferation can be maintained at a high level, a desirable property 
when culturing tissues in vitro for future transplantation.  Long scale-up times for fully 
differentiated cells is one of the limiting factors for clinical application of in vitro culture 
therapies.  The most common therapy for articular cartilage defects in the knee is 
autologous chondrocyte transplantation [3].  In this procedure autologous chondrocytes 
are harvested from the patient in an initial surgery.  These cells are then cultured in 
monolayers that are reconstructed and transplanted back into the patient after three 
weeks.  Although a generally successful operation for these patients, this method of 
differentiated cell culture is clearly not applicable to injuries that are more temporally 
constrained.  This method is also not ideal for injuries to tissues that will be significantly 
impaired by the initial cell harvest. 
Embryonic stem cells (ESCs) are pluripotent cells capable of differentiating into 
all three germ layers in the body [85].  However, despite the potential benefits of using 
ESCs, their use is extremely controversial, rendering them dormant in the clinical setting.  
Conversely, MSCs represent an autologous cell line that can differentiate into a number 
of lineages [86].  Without ethical constraints, and relative ease of extraction, MSCs 
represent a clinically feasible therapy.  MSCs have been successfully differentiated into 
endothelial cell lines using growth factors [87] or in a controlled media using ECM cues 
[80, 81].  They can also differentiate further to smooth muscle cells, which could be of 
benefit to stabilizing ECs into lumen [80].  These cells have also been shown to help in 
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vascularization pathways following injury.  MSCs are recruited to the circulatory system 
following trauma and ischemia, and then participate in healing and angiogenesis [88-92].  
Collateral perfusion can occur due to the paracrine effects of MSCs which also enhance 
EC recruitment [88, 90, 91, 93].  Furthermore, MSCs are an attractive cell line to employ 
following ischemia based on an heightened ability to engraft in vivo following exposure 
to a hypoxic environment [94]. 
2.4.2 Endothelial Progenitor Cells 
EPCs have been used extensively in cardiovascular therapies.  These cells are able 
to home to sites of ischemia and participate in neoangiogenesis (Figure 11) [83, 84].  
Asahara et al. first isolated these cells from human peripheral blood after which these 
cells differentiated into adult ECs [95].  One benefit of using EPCs is their inability to 
differentiate into non-hematopoietic cell lines.  This is in stark contrast to MSCs, which 
have the propensity to differentiate into a multitude of lineages, a behavior which could 
lead to unwanted differentiation.  In addition to being able to differentiate into endothelial 
cells, EPCs also promote re-endothelialization through paracrine factors [96].  EPCs are 
also able to cover acellular vessels in in vitro then form neovessels upon implantation 
[79].  Additional benefits of using EPCs over mature ECs are favorable survival and 
responsiveness to growth factors [63].  Although the mechanisms by which EPCs home, 
migrate, differentiate and ultimately establish an environment conducive towards 
endothelialization are nebulous, their use in biology, particularly re-endothelialization, is 
appealing. 
2.5 FLUID SHEAR STRESS ON CELLS 
A well-known factor that contributes to EC cell fate is shear force. Ott et al. have 





Figure 11.  Mechanism of EPC-mediated postnatal neovascularization. Circulating EPCs 
mobilized from bone marrow are recruited into the foci of neovascularization and contribute to 
new blood vessel formation. The intrinsic EPC activity can be augmented by certain cytokines, 
growth factors, and pharmaceutical agents. EPC indicates endothelial progenitor cell; G-CSF, 
granulocyte colony-stimulating factor; GM-CSF, granulocyte macrophage colony-stimulating 
factor; VEGF, vascular endothelial growth factor; SDF-1, stromal cell-derived factor 1.  
(Kawamoto and Losordo, 2008). 
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24 hours, followed by 25 dynes/cm
2
 for three days have better retention in vascular 
constructs once implanted into patients [33]. One suspected reason for this behavior is 
that when subjected to fluid shear stress ECs change morphology and align their actin 
filaments in the direction of the applied stress (Figure 12) [34, 35]. Shear stress not only 
directs morphological change but also affects gene expression in ECs, upregulating 
prostacyclin secretion [36], a marker for healthy endothelial activity. 
In addition to dictating cellular fate in ECs, shear flow also influences stem cell 
differentiation. Much work has been accomplished demonstrating the ability to direct 
stem cell differentiation using applied forces [97]. Forces applied to cells through 
substrate interactions [98], micropipetting [99], and shear stress [100] have all been found 
to differentiate stem cells down particular lineages. Appropriately, shear stress has been 
found to differentiate both embryonic stem cells (1.5-10 dyn/cm
2
) [101] and MSCs (15 
dyn/cm
2
) [100] towards EC lineages. Clearly, when aiming to connect a vascular 
construct to the host vascular system, preconditioning with shear stress has important 
advantages. 
2.6 ANALYSIS OF VASCULAR NETWORKS 
2.6.1 Vascular Casts Used to Elucidate Vascular Structure 
Vacular Casts (VC) have been used to image and explore the morphology of 
vascular networks and structures since the 1980’s [102, 103]. These permanent 
representations of the vascular luminal space are obtained after the process of perfusing 
the vascular system to remove blood, injecting the vasculature with resin, allowing the 
resin to polymerize, and finally removing the surrounding tissue (Vascular Corrosion 




Figure 12.  Gradual shear stress affects HUVEC morphology.  Tissue morphology of luminal surface of 
HUVEC-seeded graft subjected to 12 h shear stress of 19.7 dyn/cm
2
after 12 h stress loading of 
8.7 dyn/cm
2
 (Protocol C). SEM images; A and B. CLSM images; DiO-labeled cells, C and D; actin 
fibers, E.  (Inoguchi et al., 2007). 
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Fully perfusing the vascular network with the casting solution is of vital 
importance and determines the accuracy and usefulness of the cast as a model.  To ensure 
full perfusion and filling of the lumen, different types of resin and different viscosities of 
resin have been investigated  [104-108].  Often the tissue will also be heparanized to 
prevent blood clotting [107], occlusion of microcirulatory beds [109], and minimize 
formation of microthrombi [109].  In addition, the tissue is sometimes perfused with a 
fixative to help retain vascular structure [104, 105].  Given the lengthy process of making 
a cast (around a week depending on corrosion or clearing methods) [104, 105, 107, 109, 
110], ensuring a complete cast is vital. 
These polymer casts can then be used to accurately visualize vascular structures 
down to the capillary scale (Figure 13).  Scanning Electron Microscopy (SEM) and 
Confocal Microscopy techniques are the most commonly used to investigate the vascular 
structure preserved by the cast due to the high resolution images they are able to produce 
[109, 110].  Using stereo imaging in SEM [110, 111] and optical section stacking in 
confocal [112], three dimensional representations of the vascular network can be 
made.  From these representations vascular properties including vessel dimensions, vessel 
densities, and branching patterns can be obtained and analyzed [110].  Additionally, VCs 
have been used to elucidate differences in damaged tissues, by evaluating vessel defects, 
truncations, and extravasation patterns [113].  These techniques provide a means to gain 
insight into the continuity, and thus functionality of the vascular network that remains 
following the decellularization of various tissues. 
2.7 RESEARCH GOALS 
The focus of this work has been to create a decellularized vascular scaffold that 
removes immunogenic components of the harvested tissue while maintaining the  
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Figure 13.  Images of acrylic corrosion casts of normal lamb pulmonary vasculature. Panels A –C depict 
lungs in which casts are made of all vessels including capillaries.  Stereo microscopic images of normal 
corrosion casts (A and B) demonstrate the complexity of pulmonary vasculature, which is further 
revealed at the scanning EM level (C).  (McMullan et al., 2004). 
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biochemical availability and structural architecture necessary to support mature 
endothelial growth and vascular patency.  This scaffold was subsequently used to 
investigate the ability for vascular patency to be rescued following re-endothelialization, 
and could potentially serve as a future tissue engineering product, as well as a system to 




Chapter 3:  Development and Characterization of a Decellularized 
Vascular Scaffold 
3.1 INTRODUCTION 
To create an optimized acellular vascular tissue construct, we needed to first 
determine for which tissue source a decellularization protocol would be developed.  The 
decellularization protocol needed to effectively remove the cellular and immunogenic 
components of the harvested tissue, while leaving behind a working vascular network, 
comprised of ECM proteins—upon which optimal vascular engineering methods could be 
performed.  Highly vascular lung tissue was selected for subsequent experimentation.  
Subsequently, the OA chemical decellularization protocol that was previously developed 
by Dr. Schmidt’s lab was evaluated for its ability to decellularize lung segments of 
differing thicknesses.  A protocol was then developed and analyzed for cellularity using 
qualitative histological methods, as well as quantitative DNA concentration, and then its 
ability to preserve the ECM matrix, both in biochemical composition—determined 
through immunohistochemistry, as well as patency—determined through VCC.  The OA 
protocol was simultaneously compared to two alternative decellularization methods, 
chosen for their ability to decellularize tissue that contains a working vascular axis.  
Having outperformed the alternative decellularization methods tested, the OA method 
was chosen for subsequent experiments involving immunogenicity—evaluated by using 
an allogeneic implantation model. 
3.2 RESEARCH DESIGN AND METHODS 
3.2.1 Selecting the Optimal Tissue Source 
To create a construct that had an intrinsically organized vascular structure, we 
first evaluated potential tissue sources.  We selected liver and lung tissue based on their 
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high levels of vascularization, large vascular axes, and thickness over 200 microns.  As 
discussed earlier, tissue constructs that have a thickness of less than 200 microns may be 
vascularized by the host before significant necrosis can occur; hence, choosing a tissue 
construct that exceeds this critical size will demonstrate the effectiveness of our 
technology. 
All animal experiments were performed in compliance with the "Guide for the 
Care and Use of Laboratory Animals," [114] and IACUC standards (according to 
protocol AUP-2010-00103).  Female Fischer rats (175-200g) (Harlan, Indianapolis, IN) 
were given intraperitoneal injections of 1000U per kg of heparin sodium injection (TW 
Medical, Austin, TX) 15 minutes prior to 100/10 mg per kg of ketamine/xylazine cocktail 
(Bioniche Teoranta Inverin, Co., Galway, Ireland/Akorn Inc., Decatur, IL).  The animals 
were perfused with phosphate buffer solution until liver and lungs were blanched.  Whole 
lung and liver were excised from the animals and placed in 4
o
C buffer.  Next, the singular 
left lung lobe was isolated including its vascular axis using a stereoscope (Leica Zoom 
2000) to allow for subsequent perfusions on a single lung lobe (Figure 14). Liver tissue 
was significantly more complex when attempting to harvest a single lobe, so each lobe’s 
vascular axis was not well intact.  These tissues were then sectioned into smaller 
segments with varying thicknesses (1 mm, 2 mm, and 5 mm) to impart information 
regarding the efficacy of our technique, and then subjected to decellularization processing 
using the optimized acellular method and histological comparisons (H&E, laminin, 
DAPI) with fresh tissue counterparts.  Results of this primary selection excluded liver 














Figure 14.  Isolated left lung lobe following 
heparinization, blanching, harvest, and 
isolation.  An intact vascular axis, as well as 







3.2.2 Decellularization Selection 
Three chemical decellularization methods were selected for comparison.  The first 
method, optimized acellular (OA), was based off of a decellularization protocol 
developed previously in our lab for peripheral nerve decellularization [73].  This method 
was the only method optimized by changing the detergent incubation durations.  The 
optimized protocol used in subsequent studies is outlined.  Briefly, lung tissue was 
incubated in 125 mM sulfobetaine-10 (amphoteric) detergent for 24 hours followed by 
one rinse of 100/10 sodium/phosphate buffer  for 15 minutes.  Next tissue was incubated 
in a combination 0.14% Triton X-200 (anionic) and 0.6 mM sulfobetaine-16 (amphoteric) 
detergents for 48 hours followed by three rinses of 100/10 sodium/phosphate buffer for 
15 minutes each.  Tissue was then incubated in SB-10 solution for 15 hours followed by 
one rinse of 100/10 sodium/phosphate buffer for 15 minutes.  Tissue was then incubated 
in Triton X-200/SB-16 solution for 24 hours followed by three rinses of 50/10 sodium 
phosphate buffer.  All incubation and rinse steps were performed on a vertical rotator.  
The next method, hereby referred to as the PSDS method, was a taken from a protocol 
developed by Ott et al., effective in decellularizing heart tissue (Figure 15) [76].  Lung 
tissue was first cannulated prior to perfusion of detergents.   Next, 1% SDS (anionic) in 
deionized water was perfused through the tissue for 12 hours, followed by 15 min 
perfusion of deionized water, then 30 min of 1% Triton X-100 (nonionic) in deionized 
water.  Finally, PBS was perfused through the tissue for 124 hours to ensure the removal 
of residual detergent.  The final method (POA) combined the detergents and timings of 










   
Figure 15.  Perfusion-based decellularization using the PSDS protocol on isolated rat lung. A rapid 
clearing of the tissue was observed over one hour following the perfusion of 1% SDS solution in water.  
Note that swelling occurred over time as a result of the use of water as the solvent for the detergents. 
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3.2.3 Histological Characterization of Decellularized Lung Tissue 
Histology was the first analytical strategy to assess the composition of lung tissue 
following decellularization.  For all histological studies three unprocessed and processed 
tissues from each method were fixed in 4% paraformaldehyde for 4 hours, and then cut 
transversely into 20 µm thick sections using a cryostat (Microm HM 550). Hematoxylin 
and eosin (H&E) staining was subsequently performed on these samples and fresh lung 
as control.  Representative images of each tissue were then selected for evaluation of 
general morphology. 
Staining for the ECM proteins laminin and fibronectin was performed using 
standard immunofluorescence imaging procedures with antibodies against fibronectin 
(Sigma, F0916, 1:100) and laminin (Sigma, L9393, 1:400) on 20 µm thick sections of 
processed and unprocessed tissues.  Immunofluorescence imaging against the endothelial 
glycoprotein, CD-31 (Pharmingen, 550300, 1:50), α-smooth muscle actin (Abcam, 
ab7817) with DAPI staining for nuclei was performed on decellularized and unprocessed 
tissue sections.  Secondary antibodies attaching to either rabbit or mouse IgG and bound 
to the fluorophores, Alexa-Fluor 488, and Alexa-Fluor 568 were subsequently bound (at 
1:400).  In each study a negative control consisting of only the secondary antibodies used 
was used to prevent false-positive signal interpretation.  Representative images of each 
tissue were then visualized on an Olympus IX70 (Olympus America, Melville, NY) 
inverted microscope, and captured with an Optronics (Goleta, CA) MagnaFire digital 
color camera. For each stain, a fixed exposure time was used. 
3.2.4 DNA Quantification 
To quantitatively compare the efficacy of the different decellularization methods 
used to remove cellular material, we isolated the DNA remaining from our scaffolds 
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compared to fresh lung tissue.  Processed and unprocessed lung tissue (three lungs per 
technique) was rapidly frozen with liquid nitrogen and crushed using a mortar and pestle.  
Three 50 mg samples per lung were then incubated in 40 mM NaOH solution for 5 hours 
at 90
o
C, and then neutralized with Tris-HCl to a pH of 7.8.  These samples were then 
centrifuged at 500g for 15 min.  The supernatant was then drawn and run with a 
NanoDrop machine to read the optical density at 260 nm and calculate the corresponding 
ds-DNA concentration. 
3.2.5 Vascular Casting 
General Vascular Corrosion Casting 
Mercox II CL-2R resin with catalyst (40% benzoyl peroxide) was injected via 
syringe pump (KD Scientific, Model 200) (0.2 g catalyst/ 10 ml resin) at 2 ml/min into 
the vascular axis of six processed and two unprocessed tissues at 2 ml/min (Figure 16). 
The resin was allowed to polymerize in water baths at 65
o
C overnight, after which the 
organic components were removed by chemical washes (25% potassium hydroxide 48 
hours), and warm water washes to remove remaining tissue.  Photographs were taken 
using a standard digital camera through a stereoscope (Leica Zoom 2000). 
Quantitative VCC 
The presence of capillaries in the remaining plastic structure was visualized using 
scanning electron microscopy (SEM). The plastic molds were air dried for 24 hours in the 
hood, then coated with 20 nm platinum palladium for observation with SEM (Zeiss Supra 
40 VP) with an acceleration voltage of 5 kV.  A total of 32 images were taken for each 
decellularization method, and then normalized to account for the same total surface area 




Figure 16.  Mercox injection in the pulmonary artery of decellularized lung tissue.  Perfusion 
demonstrates uniform filling, and exiting through the pulmonary vein. 
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images for extravasations of the resin from the luminal space.  Extravasations were 
counted and sorted by diameter in four categories:  <10 µm, 10-20 µm, 20-30 µm, and > 
30 µm.  These counts were normalized with respect to the area of the image, and then 
averaged for each decellularization group.  Each decellularization group was then 
averaged among the four researchers.  Total extravasational volume was determined by 
estimating the average diameter of extravasations found in each category as 5µm, 15 µm, 
25 µm, and 30 µm.  A paired t-test was used to determine if statistical significance 
existed between the researcher’s counting for each decellularization group.  An F-test 
was used to determine variance significance followed by a Student’s t-test to determine 
statistical significance between each decellularization group. 
3.2.6 Testing Immunogenicity of an Optimized Acellular Vascular Scaffold 
Following the extensive testing on the efficacy of our decellularization protocol, 
we were able to confirm that our OA vascular scaffold was superior in maintaining 
vascular patency while removing the potentially immunogenic cellular material.  
Subsequent testing was performed using this superior decellularization protocol. 
To gain a practical understanding of the potential immunogenicity of our scaffold 
following the OA process, we developed an in vivo allogeneic implantation model.  24 
lungs from 175-200g female Fischer rats (Harlan, Indianapolis, IN) were isolated and 
decellularized using the OA process, as mentioned previously.  12 lungs were implanted 
subcutaneously into 175-200g Lewis rats (Harlan, Indianapolis, IN); whereas 12 were 
implanted subcutaneously into Fischer rats of the same size as an isogenic control.  Rats 
were anesthetized with isofluorane vapor at 4% induction and 2.5% during surgery. A 
skin incision was made on the right flank of 2-5 month old Lewis rats where either 
decellularized or unmodified lung tissue was anchored to the thigh via 5-0 sutures 
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(Ethicon). Following surgery, animals received injections of buprenorphine, or saline 
when necessary. An equal number of animals were maintained for one and four weeks, 
after which they were euthanized and the implants were excised for histological analysis 
as described for tissue harvest. No complications arose.  Basic H&E staining was used to 
assess general signs of immunological rejection. Additionally, thin tissue sections were 
obtained and used to determine the number of monocytes and macrophages (mouse anti-
macrophage, Millipore, MAB1435, 1:50) within the grafts, using standard 
immunohistochemistry protocols [74].  Fifteen images from six sections of three tissues 
of both allograft and isograft were compared to each other for immune positive cell 
counts.  These counts were then compared to the total number of cells in the field of 
view.  Total cell counts were determined by running the DAPI image through a 
convolution filter in ImageJ (Bethesda, MD), then inverting and thresholding the image 
before applying a watershed process, then finally using the analyze particles application. 
3.3 RESULTS 
The optimization of our decellularization protocol—to create a scaffold devoid of 
cellular markers while still maintaining a vascular architecture down to the capillary 
scale—began by testing the efficacy of an already optimized acellular protocol for nerve 
tissue.  Although optimized from nerve and tested on lung and liver—which are vastly 
different in terms of thickness, and area—the optimized acellular protocol provided 
excellent clearing of cellular components while maintaining structural integrity of the 
ECM of lung tissue of different thicknesses and arrived at our OA protocol.  We then 
extended the detergent incubation times to account for the thicker tissue source.  The 
extent to which the cellular material was removed, and the architecture was preserved in 
lung tissue was analyzed in greater detail using both qualitative histological means, as 
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well as quantitative methods.  H&E staining and immunohistochemistry revealed a 
comparable architecture to unprocessed tissue, and the ability for antibodies targeting 
specific domains on the ECM to bind and signify bioactivity, while demonstrating the 
removal of nuclei.  As a comparison, alternative decellularization methods were also 
analyzed and revealed the superiority of the OA process.  Quantification of the removal 
of nucleic material, the protein remaining, and the damage to the vascular network 
following the OA process were then analyzed using DNA isolation, and qVCC 
techniques—again demonstrating the superiority of the OA method compared to 
alternative methods.  Following characterization, the OA vascular scaffolds demonstrated 
a lack of immunogenicity using an in vivo allogeneic model, with isogenic comparison. 
3.3.1 Optimized Acellular Decellularization 
Segments of lung and liver (1, 2, and 5 mm thicknesses) were decellularized using 
the optimized acellular protocol developed in our lab previously.  Initial analysis using 
H&E, and immunostaining against laminin with DAPI counterstain revealed the ability 
for the optimized acellular method to effectively remove cellular components of each 
thickness of lung (Figures 17, 18).  Liver segments failed to decellularize in more than a 
few hundred microns of the tissue, even in thinner segments (Figure 18).  Following 
decellularization of segments, the singular left lung lobe was harvested and decellularized 
in its entirety.  Although largely effective at removing cellular material, there were still 
residual components found in the tissue.  To combat this problem, and spurred by the 
preservation of ECM even in thin lung segments, the detergent incubation times were 
doubled.  The doubled detergent incubation time removed cellular material without the 






Figure 17.  H&E staining for optimized acellular decellularized lung segments of different 
widths.  H&E staining reveals an organized structure remains across all thicknesses of lung 











Figure 18.  Initial decellularization of liver and lung tissue.  Overlay of DAPI (blue) and laminin (red) staining 
for liver (A) and lung (B) following the OA protocol.  The liver displays a gradient of decellularization from 















Figure 19.  Increasing OA detergent incubation time improves decellularization.  Staining against CD-31 
(green) with DAPI (blue) of fresh (A) and decellularized (B, C) lung following OA processing at standard 
timing (B) and lengthened timing (C).  Standard timing OA decellularization removes the presence of nuclei, 
but fails to remove the transmembrane glycoprotein CD-31, whereas long-time OA decellularization 
effectively removes all cellular components.  Scale bar = 100 µm 
 47 
cellular markers using immunohistochemistry (Figure 19).  Further characterization of 
the tissue was then compared to other decellularization protocols. 
3.3.2 Optimized Acellular Process Effective at Removing Cellular Material while 
Preserving ECM Content 
Hematoxylin and Eosin Staining for General Ideas on Tissue Composition 
Several qualitative histological methods were implemented to assess the composition of 
lung tissue following different decellularization protocols.  The first most general method 
used was H&E staining—to examine the broad architecture of the lung in comparison to 
fresh lung samples (Figure 20).  H&E demonstrated that nucleic material was removed 
and ECM persisted in each of the decellularized lungs.  An organized structure similar to 
native tissue was visualized following tissue processing using all the decell methods.  
General continuity of basal ECM was found following each decellularization 
method.  Some erratic hematoxylin staining was seen in following the PSDS method and 
to a lesser extent, the POA method; this however, was likely due to anionic SDS 
detergent binding to the basal proteins, as opposed to genetic material—which will be 
thoroughly discussed in the following section. 
Immunohistochemistry Demonstrates ECM Activity and Cellular Removal 
Immunohistochemistry techniques also provided a qualitative representation of 
cellular material left over.  As mentioned in the previous section, the first procedure 
based on the optimized acellular protocol for nerve was ineffective in removing residual 
fragments of cellular material; although effective in removing nuclei.  
Immunofluorescence evaluation reveals the removal of nucleic material.  Some positive 
DAPI staining was seen in perfusion decell groups (Figures 23, 24); however, this was 

























Figure 20.  Hematoxylin and eosin (H&E) staining following different decellularization methods on lung tissue.  
Fresh (A), diffusion OA (B), PSDS (C), POA (D) lung were examined. No presence of intact nuclei remained, 
however, in PSDS processing, basophilic staining from hematoxylin was observed.  ECM preservation was most 




staining.  Immunofluorescence signal using antibodies targeting the endothelial marker 
CD-31 and α-SMA was greatly diminished following decellularization, although some 
signal was seen in the POA group (Figures 21, 22).  In contrast, positive signal for 
antibodies for laminin and fibronectin, demonstrated a bioactivity of these domains in 
each decellularization method used comparable to fresh lung tissue (Figures 21, 23). 
3.3.3 DNA Quantification Confirms Removal of Nucleic Material Following 
Decellularization 
Fresh lung DNA isolation was compared to DNA isolated from segments of lung 
following decellularization (Figure 25).  Spectral analysis and quantification confirmed 
the removal of DNA observed in qualitative histological methods.  DNA concentration 
from each decell group was significantly lower than fresh tissue.  OA, PSDS, and POA 
lungs resulted in 85%, 91%, and 87% less ds-DNA than fresh tissue respectively.  Each 
decellularized DNA concentration was significant to fresh tissue (p<0.0000001), and 
significance was observed between the OA and PSDS group (p<0.0001).  Importantly, 
the 260/280 nm wavelength ratios of OA, PSDS, and POA lungs were 1.75 ± 0.06, 2.07 ± 
0.15, and 1.87 ± 0.09 respectively, compared to 1.74 ±0.04 for fresh tissue and close to 












Figure 21.  CD-31 and laminin immunostaining following different decellularization methods on lung.  
Immunostaining against laminin (red), and the endothelial marker CD-31 (green) demonstrates basal lamina 
remains whereas cellular signal is diminished following decellularization of lung tissue using different 









Figure 22.  α-smooth muscle actin immunostaining following different decellularization methods on 
lung tissue. Staining against α-smooth muscle actin demonstrates attenuation of  the cellular component 
following decellularization methods (A, fresh lung; B, OA method; C, PSDS method; D, POA method) 




















Figure 23. Fibronectin and DAPI immunostaining following different decellularization methods on lung 
tissue.  Staining against fibronectin (red) demonstrates preservation of ECM biochemistry and organization 
when compared to fresh tissue (A). Higher organization was found in the groups using OA detergents; 
diffusion (B) and perfusion (D), compared to the PSDS method (C).  Removal of nuclei through DAPI 
counterstain (blue) was seen following decellularization; however residual cationic staining is evident in 








Figure 24.  Staining for DAPI reveals removal of nuclei following decellularization of lung tissue using 
different methods (A, fresh lung; B, OA method; C, PSDS method; D, POA method).  Residual anionic 






Figure 25.  DNA concentration was determined using a NanoDrop spectrophotometer.  Lung tissue 
decellularized using OA, POA, and PSDS methods demonstrated a significant decrease in 
concentration when compared to fresh tissue.  The 91% decrease in DNA concentration following 
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3.3.4 Vascular Corrosion Casting 
Qualitative Evaluation of Casts 
During VCC perfusion of each decellularization method, all of the Mercox resin 
was seen go into the pulmonary artery and exit through the pulmonary vein.  The 
resulting casts all retained the shape and configuration of the lung, with a visible vascular 
axis intact.  Macroscopically, the color of the casts appeared different.  The fresh lung 
control was the most white in color, whereas perfusion decell methods had more color to 
them (Figure 26).  Electron micrographs enabled capillary formations to be seen.  The  
perfusion-decell groups failed to maintain vascular integrity at the capillary scale; 
whereas the OA decell group preserved capillary-like networks (Figure 27). 
Quantitative VCC Analysis 
Whereas differences were difficult to elucidate between the decell methods from 
histology, analysis of extravasations gave rise to distinct trends depending on tissue 
processing (Table 1).  The fresh control had very few extravasations across all sizes.  The 
OA method had a large number of extravasations less than 10 µm in diameter, but less 
extravasations of 10-20 µm, and significantly less 20-30 µm and over 30 µm 
extravasations when compared to the other decell methods.  In addition, the total volume 
of resin that escaped OA tissue was substantially less than the perfusion decell methods 
(Figure 28).  These results suggest that greater damage was done to the lumina of tissue 
processed through perfusion-based decellularization methods, than the OA method. 
3.3.5 Subcutaneous Implantation of OA Scaffolds in vivo Present Normal 
Immunogenic Response 
Following explantation, grafts from the allogeneic model, as well as the isogenic 








Figure 26. VCC of lungs following decellularization using different methods (A, fresh lung; 
B, OA method; C, PSDS method; D, POA method) reveals a defined geometry of mimicking 
the original tissue structure.  The color of the casts appears to range from white to pink in 







Figure 27.  SEM images of VCC of lungs following decellularization using different methods (A, 
fresh lung; B, OA method; C, PSDS method; D, POA method).  Fresh tissue displays a highly 
organized structure with intact vessels branching to capillary networks.  OA method has some 
disorganized features to its capillary structure.  The perfusion methods (PSDS and POA) are 
highly disorganized.  Extravasations (asterisks) are most prevalent in the perfusion methods.  The 





Table 1.  Extravasation Counts per mm
2
 for Different Decellularization Methods 
 Decellularization Method 
Extravasation 
Diameter Fresh OA PSDS POA 
Less than 10 95.26 ± 113.8 4125.19 ± 4978.53* 418.76 ± 541.80† 4494.30 ± 2691.37*‡ 
10 to 20 24.01 ± 40.96 119.44 ± 11.70* 374.99 ± 474.49* 464.08 ± 425.11*† 
20 to 30 3.37 ± 9.80 9.80 ± 19.5 71.78 ± 87.78*† 55.55 ± 65.25*† 
Greater than 30 3.80 ± 5.88 2.56 ± 10.2 246.28 ± 148.39*† 18.15 ± 23.84*†‡ 
Asterisk, dagger, and double dagger denote significance (p<0.05) versus fresh, OA, and PSDS groups respectively 
Table 1.  Extravasation counts following vascular corrosion casting of fresh and decellularized lung tissue plus or 
minus one standard deviation.  A greater number of extravasations less than 10 microns in diameter was seen in OA 
decellularized lung casts compared to fresh and PSDS casts; however, larger extravasation counts for OA casts were 
not significantly different from fresh tissue, whereas PSDS and POA casts displayed significance versus fresh tissue.   
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Figure 28.  Total extravasation volume was calculated per mm
2
 by cubic micron for each 
decellularization method investigated.  The amount of vascular damage correlated with larger 
extravasations was apparent when assessing the volume of resin that escaped the vascular space of the 
tissue.  Although damage was found following each decellularization method, the diffusion based OA 
method was by far the most effective at preventing the escape of resin from the remaining vascular 















































already encapsulated in fibrous tissue.  At four weeks in all animals, the capsule 
surrounding the scaffold was thicker, and the scaffold was fully cellularized, remodeled 
to a flat circular morphology, and substantially smaller in size (Figure 29). 
General histological analysis through H&E revealed similar fibrous encapsulation 
between isograft and allograft tissues at one and four week implantation duration.  
Immunohistochemistry targeting macrophages revealed additional similarities amongst 
groups in each implantation duration (Figures 30, 31).  Specifically, in one-week 
implantation groups, macrophage counts per total cell count were 0.059 and 0.068 for 
isografts and allografts respectively and not statistically significant (p>0.35) (Figure 32).  
Total cell counts within the isograft scaffolds were more than double the allograft 
scaffold (23,503 and 11,125).  Following one week, macrophages were most commonly 
found surrounding the tissue, whereas few macrophages were present within the 
scaffolds.  Although some cellular penetration was seen following one week, most cells 
were found within a few hundred microns from the exterior of the scaffold; however, 
mass cellular infiltration was observed surrounding the bronchus of the scaffold—with 
few macrophage cells present (Figure 30). 
Following implantation for four weeks, scaffolds revealed full cellular infiltration.  
Isografts and allografts maintained fewer immunogenic cells per nuclei compared to one-
week explants (0.021 and 0.009 respectively, and were statistically significant p<0.00001 
against one-week explants) (Figure 32).  The total number of cells counted in each group 
was nearly equivalent as well at 74,279 for allografts and 74,456 for isografts—a 






Figure 29.  Right flank of a rat opened following four weeks in vivo to reveal the subcutaneous 
OA implant.  Extensive remodeling of the tissue was visualized.  The formerly white 
decellularized scaffold is now tan, demonstrating cellular infiltration.  Fibrous encapsulation 






Figure 30.  Isogenic (A,B) and allogeneic (C,D) OA explants harvested one week following subcutaneous 
implantation demonstrated similarities in cellular infiltration.  Staining for the macrophage marker ED1 
depicted increased macrophage counts in the fibrous scar surrounding the OA scaffold when compared to 
inside the scaffold in isografts (A) and allografts (C).  Increased cellular infiltration into the OA scaffolds was 
seen near the bronchus in both isograft (B) and allograft (D).  This cellular infiltration failed to stain positively 



















Figure 31.  Isogeneic (A, C) and allogeneic (B, D) OA explants harvested one week following 
subcutaneous implantation demonstrated similarities in cellular infiltration.  Staining for the macrophage 
marker ED1 depicted increased macrophage counts per total cell count in the fibrous scar surrounding the 
OA scaffold (A,B) when compared to inside the scaffold (C,D).  Cells were able to completely 
recellularize the center of the scaffolds (C, D), compared to explants harvested after one week following 












Figure 32.  The number of ED1 positive cells was counted following immunohistochemistry and 
image processing of isograft and allograft OA scaffolds subcutaneously implanted for one and four 
weeks.  This number was then divided by the total number of cells counted then averaged.  
Significance occurred between the one and four week groups as well as between isografts and 
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The OA process was successfully adapted to decellularize lung tissue leaving 
behind capillary-like structures while effectively eliminating cellular material.  This was 
demonstrated through general histology, immunohistochemistry, HPLC analysis, DNA 
quantification, and VCC methods.  Immunogenicity of this scaffold was then tested 
revealing the inert nature of the decellularized tissue following subcutaneous 










Chapter 4:  Re-endothelialization of a Decellularized Vascular Scaffold 
4.1 INTRODUCTION 
The previous chapter described the development and characterization of a process 
to effectively decellularize lung tissue.  The advantages of the OA process were verified 
through comparisons with alternative decellularization methods, and enabled further 
investigations to be performed using this substrate.  This chapter delves into the capacity 
for the OA scaffold to support re-endothelialization, as well as the implications re-
endothelialization have on the performance of the OA scaffold as a vascular engineering 
tool.  Subsequent experiments involving re-endothelialization were evaluated using 
US/PA imaging and histology, and the effects that re-endothelialization have on 
recovering vascular patency were evaluated by using VCCs and comparing clotting 
proclivity following the perfusion of whole-blood into OA scaffolds with and without 
cells. 
4.2 RESEARCH DESIGN AND METHODS 
4.2.1 Culture and Incubation of Endothelial Cells with Gold Nanotracers 
HDMECs were obtained from Promega (Heidlberg, Germany); HUVECs were 
obtained from Lonza (Basel, Switzerland).  These cells were plated with an initial 
seeding density of 10,000 cells/cm
2
 for HDMECs and 5,000 cells/cm
2
 for HUVECs, then 
expanded and used from passage three to seven in all studies.  Gold nanotracers were 
added to the cells for observance with photoacoustic absorbance as described previously 
[115, 116]. Briefly, 10
12
 nanoparticles/ml of media were used to incubate cells, with 200 
μl/cm
2
 of nanoparticle medium added to the cell culture for 24 hours. 
These nanotracer loaded cells were then expanded to confluency (typically 5 days 
following an initial seeding density of 10,000 cells/cm
2




for HUVECs) and imaged using phase contrast, darkfield, and brightfield 
imaging to observe the uptake of nanoparticles, as well as general morphological 
behavior. 
Cytotoxicity was analyzed using a standard MTS assay (CellTiter 96® Aqueous 
One Solution CellProliferation Assay, Promega, Madison, WI).  HDMECs and HUVECs 
were seeded in gold nanotracers for 24 hours as described previously in a standard 24-
well plate at 10,000 and 5,000 cells/cm
2
 respectively.  Each cell type was allowed to 
grow for 24 and 72 hours following the addition of nanotracers before subsequent 
analysis.  The MTS dye was then added to the cells at 20% the normal media volume for 
four hours at 37
o
C.  Next, 240 µl MTS solution was taken in triplicate from each well and 
read in a 96-well plate at 490 nm wavelength.  For each cell type a standard curve for 
cells was created to ensure assay accuracy. 
4.2.2 Ultrasound-Guided Photoacoustic Imaging of Re-endothelialized Scaffolds 
Scaffolds re-endothelialized with cells containing gold nanotracers were imaged 
using ultrasound-guided photoacoustic imaging.  Following re-endothelialization, 
scaffolds were incubated in 4% paraformaldehyde for four hours then imaged.  
Ultrasound and photoacoustic signals were captured using a 20 MHz array transducer 
with Vevo 2100 ultrasound micro imaging system (VisualSonics, Inc.). A tunable OPO 
laser beam (Premiscan, GWU, Inc.) pumped by a pulsed Nd:YAG laser (Quanta-Ray, 
Spectra Physics, Inc.) was delivered through an optical fiber bundle (Ceramoptec, Inc.). 
The fiber bundle was combined with the ultrasound transducer and aligned such that the 
transmitted light would focus at the focal point of the transducer using a positional stage 
(Zaber, Inc.). The trigger signal from the laser system was synchronized with the 
computer or the Vevo 2100 imaging system to capture the photoacoustic signal when the 
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pulsed laser irradiated. Once the photoacoustic transient and ultrasound pulse-echo signal 
was captured, the off-line image processing was performed with the acquired imaging 
data.  The magnitudes of the ultrasound and photoacoustic signals were calculated by 
taking the absolute values of analytic signals obtained using the Hilbert transform. The 
photoacoustic signal magnitude was then compensated for wavelength dependent laser 
fluence. The compensated ultrasound and photoacoustic signals were interpolated to 2D 
images. The combined ultrasound and photoacoustic images were created by overlaying 
photoacoustic intensities higher than a user-defined threshold on the grayscale ultrasound 
images.  The scaffolds were imaged at 700 nm wavelength with a fluence around 10-13 
mJ/cm
2
.  As a control, scaffolds devoid of cells were imaged for PA signal as well.  As a 
further confirmation of cellularity following US/PA imaging, scaffolds were sectioned 
with a cryostat to observe the phenotype of the cells present in the scaffolds using 
immunohistochemistry. 
4.2.3 Re-endothelialization Optimization in Optimized Acellular Scaffolds 
To evaluate whether aggregation would occur in capillaries, gold nanoparticles 
(3x10
12
 nanoparticles in 3 ml of media) were injected into the vascular axis of the OA 
scaffold, and then imaged with US/PA imaging to visualize distribution. 
Next, endothelial cells incubated with gold nanotracers were perfused into the 
vascular axis of the OA vascular scaffolds using perfusion methods described previously 
for VCC.  Concentration and number of perfusions were altered to ensure cells were 





 cells/ml, and either delivered in a single bolus injection, or divided into three 
injections of three ml over two hours.  Cells with nanotracers were injected into the 
vascular axis at two ml/min using a syringe pump (KD Scientific 200).  Each Using 
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US/PA imaging to observe cellular distribution, it was determined that three injections of 
3 ml over a 3 hour time span with a concentration of 10
6
 cells per ml provided optimal 
cell distribution in the scaffold. Cells were then allowed to adhere to the substrate 
overnight before the addition of pulsatile flow. 
4.2.4 Pulsatile Cell Culture 
Unless otherwise stated, all components of the system were autoclaved to 
maintain sterility, and all setup was performed in a vertical or horizontal flow hood.  To 
connect the tissue to the pump we used the same modified 24-gauge cannula that was 
used in VCC that was e-beam sterilized prior to use.  The cannula was connected to 
prefilled #16 tubing platinum cured silicone tubing (Masterflex, Germany) with a male 
fitting.  This tubing was fed through an autoclavable 100x15 mm petri dish (Thermo 
Scientific, Waltham, MA) through a hole drilled smaller than the outer diameter of the 
tubing.  This tubing was then run through a rubber plug that allowed for eventual access 
to the interior of the cell incubator while keeping the pump head free of humidity.  The 
other end of the tubing was fed through another hole in the petri dish that allowed for 
circulation of media. 
To sterilize the lung prior to loading cells, the isolated left lung was exposed to 17 
kGy of radiation using an electron beam (Nutek Corp., Hayward, CA).  Cells were 
subjected to pulsatile flow using a peristaltic pump (iPumps, Type A) while following a 
gradual shear flow culturing protocol [35].  Briefly, pulsatile shear stress of 3.2 dyn/cm
2
 
for 24 hours, followed by 8.7 dyn/cm
2
 for 12 hours, and finally 19.6 dyn/cm
2
 for 24 hours 
was delivered to cells.  The flow rates necessary to deliver these shear stresses were 
calculated using the Hagen-Poiseuille equation (eq. 1), assuming a tube diameter at the 







After the 60 hour shear conditioning was concluded, scaffolds were cleared of 
media by perfusing PBS through the system in a series of washes.  To aid in the transfer 
of solutions by completely clearing the tubing while preventing air bubbles from entering 
the tissue, the cannula was detached from the system with sterile forceps, then reattached.  
The lung was then directly fixed with 4
o
C 4% paraformaldehyde for 5 minutes, then post-
fixed for four hours.  The cannula and suture was then removed in samples for US/PA 
imaging and histology, or left in for samples that would be immediately cast with resin. 
Histology was performed to assess the scaffold following re-endothelialization.  
Immunostaining against VE-cadherin (Abcam, 33168), CD-31, and DAPI following 
standard immunohistochemical protocols was performed.  The secondary antibodies were 
goat anti-rabbit AlexaFluor 488, and goat anti-mouse AlexaFluor 568 (1:400). 
4.2.5 Vascular Casting of Re-endothelialized Scaffolds 
Following re-endothelialization, scaffolds were perfused with Mercox II CL-2R 
for VCC inspection using methods described previously.  These VCC were used to obtain 
both a general sense of the preservation of vascular networks, and also images for qVCC 
as described previously with acellular scaffolds alone.  VCC results from re-
endothelialized scaffolds would be compared to the data obtained from acellular scaffolds 
alone to elucidate what extent re-endothelialization had on recovering the vascular 
patency within the acellular scaffold. 
4.2.6 Whole-Blood Perfusion Assay 
To understand how vascular patency might pertain to real-life applications, a 
whole-blood perfusion and clearing procedure was developed.  50 ml of PBS was 
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perfused into re-endothelialized, OA vascular scaffolds alone, and fresh lung prior to 
blood perfusion.  Whole-blood from humans (Sanguine Biosciences, Valencia, CA) was 
strained through a 70 micron nylon-mesh sterile cell strainer (Fisher Scientific) before 
being perfused into the various scaffolds.  The PBS and blood were perfused into our 
scaffolds via a peristaltic pump at 5.8 ml/min.  Following blood perfusion, the scaffolds 
were perfused with 100 ml PBS.  Photographs were taken before and after perfusion with 
blood and PBS.  Next, the scaffolds were fixed with 4% paraformaldehyde for four hours 
and sectioned for histology and immunohistochemistry targeting platelet formations, 
using CD-31 and DAPI. 
4.3 RESULTS 
Testing the ability of the OA scaffold to support re-endothelialization began by 
selecting two endothelial lineages, a system to support perfusion-culture, and a technique 
to monitor the cellular distribution.  Both cell lineages were able to be successfully 
injected into scaffolds and subsequently subjected to perfusion-culture using a peristaltic 
pump and a chamber to house the scaffold.  Using ultrasound-guided photoacoustic 
(US/PA) imaging allowed us to visualize cellular distribution throughout the entirety of 
the scaffold.  To use US/PA imaging, cells need to be incubated with gold nanotracers.  
We first had to ensure that the cells tolerated incubation, verified through an MTS assay.  
The functionality of the vascular network of the OA scaffold with and without cells was 
compared using vascular corrosion casting (VCC), and revealed an improved structure 
both qualitatively and quantitatively.  The improved vascular structure in re-





4.3.1 Endothelial Cells Cultured with Gold Nanotracers Exhibit Normal Morphology 
and no Cytotoxicity 
HDMECs and HUVECs first incubated with gold nanotracers, then cultured to 
confluency demonstrated normal morphology (Figures 33, 34).  HDMECs and HUVECs 
demonstrated a cobblestone-like morphology indicative of healthy endothelial cells when 
confluent.  Also, cytotoxicity results indicated through the use of an MTS assay reveal 
that the incubation of nanoparticles failed to decrease cellular viability (Figures 35, 36).  
Although there was a significant difference between HUVECs monitored 24 hours 
following the addition of nanoparticles (p<0.01), the difference in observed MTS 
fluorescence intensity at 490 nm for cells cultured with nanoparticles was only 15% less 
than intensity observed in cells cultured without nanoparticles.  Furthermore, although 
statistically insignificant (p>0.35) at 72 hours following the addition of nanoparticles, the 
fluorescence intensity for cells cultured with nanoparticles was 9% greater than cells 
cultured without nanoparticles. 
Each standard for the MTS assay demonstrated a linear relationship between cells 
and fluorescence intensity. 
4.3.2 Optimized Injection Parameters Enable Uniform Cellular Distribution 
The blank OA decellularized scaffold was a devoid of PA signal when applying 
US/PA imaging (Figure 37).  The initial bolus injection of nanoparticles into the vascular 
axis of the OA scaffold revealed PA detection only present near the pulmonary artery of 
the tissue (Figure 38).  Although, media was able to perfuse fully through the vein of the 








Figure 33.  Effects of nanoparticle incubation on HDMEC morphology.  HDMECs incubated with gold 
nanoparticles overnight, then allowed proliferate near confluency (A-C) displayed similar morphology 
as HDMECs plated without nanoparticles (D-F).  Phase-contrast imaging reveals cobblestone 
morphology in nanoparticle and control groups (A, D) and a departure from spindle-like morphology.  
Dark-field and bright-field imaging demonstrate the presence of nanoparticles (B, C) compared to 
control (E, F).  Scale bar = 50µm. 
A B C 
D E F 
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Figure 34.  Effects of nanoparticle incubation on HUVEC morphology .HUVECs incubated with gold 
nanoparticles overnight, then allowed proliferate near confluency (A-C) displayed similar morphology 
as HUVECs plated without nanoparticles (D-F).  Phase-contrast imaging reveals cobblestone 
morphology in nanoparticle and control groups (A, D) and a departure from spindle-like morphology.  
Dark-field and bright-field imaging demonstrate the presence of nanoparticles (B, C) compared to 
control (E, F).  Scale bar = 50 µm. 
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Figure 35.  Following incubation with gold nanotracers for 24 hours, HDMECs were maintained for 
24 and 72 hours then incubated with MTS for four hours.  The culture media and MTS dye were then 
imaged on a 96-well plate in triplicate at 490 nm.  HDMECs incubated with did not exhibit abnormal 


































Figure 36.  Following incubation with gold nanotracers for 24 hours, HUVECs were maintained for 
24 and 72 hours then incubated with MTS for four hours.  The culture media and MTS dye were then 
imaged on a 96-well plate in triplicate at 490 nm.  Although the metabolic activity of HUVECs 
cultured with nanotracers was significantly less than HUVECs cultured without nanotracers at 24 

































Figure 37.  Ultrasound-guided photoacoustic imaging of an optimized acellular scaffold.  Imaging 
reveals absence of photoacoustic signal at 750nm.  A void in the scaffold representing the bronchus can 
be seen in cross-sections of the ultrasound images (arrow). 
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Figure 38.  Nanoparticle injection into an OA scaffold.  A single bolus injection of nanoparticles into 
the pulmonary artery of an OA scaffold demonstrates localization towards the entry point (arrow).  
Nanoparticles likely clogged the smaller vessels, allowing for plasmonic coupling, red-shifting, and 
resulting photoacoustic signal detection at 750nm to occur.  Media was rinsed out then tissue was fixed 




The results of various injection parameters demonstrated the importance that 
concentration would have on aggregation and thus establishing a uniform cellular 
distribution.  Using a single bolus injection of 3x10
6
cells in 9 ml media resulted in 
aggregation and clustered distribution of cells (Figure 39).  When the injections were 
spread out to a series of three injections of 10
6
 cells/ one ml media, the distribution was 
improved for HUVECs and HDMECs (Figures 40, 41).  This optimized re-
endothelialization plan was then adopted for subsequent studies. 
Following re-endothelialization and staining for VE-cadherin, CD-31 and DAPI 
several observations were made (Figure 42).  Although uniform distribution could be 
visualized through US/PA imaging, and cells were found throughout the scaffold 
sections, at the cellular level the entirety of the scaffold was not cellularized.  Brightfield 
imaging revealed the presence of cells in the locations of nuclei visualized fluorescently 
(Figure 42); however, although a minority, there were also nanoparticles present which 
were not associated with nuclei, but were positive for CD-31 and VE-cadherin markers.  
The majority of the media that exited the pulmonary vein of the scaffold after perfusion 
contained intact cells, not damaged cells.  Positive CD-31 imaging was observed and 
generally associated with positive staining for VE-cadherin.  These results point at the 
need to refine the cell concentration for re-endothelialization. 
4.3.3 Re-endothelialization of OA Scaffolds with HDMECs Improves Vascular Patency 
down to the Capillary Scale 
Following re-endothelialization and perfusion culture using both HUVECs and 
HDMECs, photoacoustic signal revealed that cells were well-distributed in the scaffolds 
(Figures 43-45).  Creating VCCs of these re-endothelialized scaffolds enabled 
differences in patency to be observed down to the capillary scale (Figure 46).  Cellular  
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Figure 39.  Single bolus injection of HUVECs into an OA scaffold.  A single bolus 
injection of 2.5x10
5
 HUVECs with gold nanoparticles in 4.5ml media results in poor 
distribution of cells in an OA scaffold.  Media was rinsed out then tissue was fixed prior 




Figure 40.  Multiple injections of HUVECs into an OA scaffold.  Three injections of 
8.3x10
4
 HUVECs with gold nanoparticles in 1.5ml media over two hours results in 
better distribution of cells within an OA scaffold.  Media was rinsed out then tissue was 




Figure 41.  Multiple injections of HDMECs into an OA scaffold.  Three injections of 
1.6x10
5
 HDMECs with gold nanoparticles in 3.3ml media over two hours results in 
distribution of cells within the entirety of an OA scaffold.  Media was rinsed out then tissue 
was fixed prior to US/PA imaging at 750nm. 
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Figure 42.  Histological analysis of re-
endothelialized tissue.  HDMEC injected into 
OA decellularized scaffolds with staining for 
CD-31 (A), VE-Cadherin (C).  Tissue was not 
extensively cellularized, intimating at the need 
for more optimization.  CD-31 positive 
staining matched up with VE-Cadherin.  
Although association with nanoparticles was 
observed (B), some nanoparticle aggregation 
can be visualized without positive staining for 






Figure 43.  Perfusion culture following HUVEC re-
endothelialization.  Three injections of 3.3x10
5
 HUVECs with gold 
nanoparticles in 3.3 ml media over two hours were delivered to an 
OA scaffold.  Cells were allowed to adhere overnight before 
gradually increasing perfusion flow was administered (3.2 dyn/cm
2 
for 24 hours, 8.7 dyn/ cm
2 
for 121 hours, 19.6 dyn/ cm
2 
for 24 hours).  
Photoacoustic signal from cells at 750nm indicates the retention of 
cells distributed within the entirety of an OA scaffold at the 
conclusion of the culture.  Cross sections from rows A , B, and C, 
depict slice #180, #130, and #70 respectively (D).  Note the void 
represented by the bronchus is still present following culturing, 
demonstrating cellular infiltration did not occur (B, arrow).  Media 










Figure 44.  Perfusion culture following HDMEC re-endothelialization. 
Three injections of 3.3x10
5
 HDMECs with gold nanoparticles in 3.3 ml 
media over two hours were delivered to an OA scaffold.  Cells were 
allowed to adhere overnight before gradually increasing perfusion flow 
was administered (3.2 dyn/cm
2 
for 24 hours, 8.7 dyn/ cm
2 
for 121 
hours, 19.6 dyn/ cm
2 
for 24 hours).  Media was rinsed out then tissue 
was fixed prior to US/PA imaging at 750nm.  Photoacoustic signal 
from cells at 750nm indicates the retention of cells distributed within 
the entirety of an OA scaffold at the conclusion of the culture.  Cross 
sections from rows A , B, and C, depict slice #180, #130, and #70 
respectively (D).  Cross sections appear to have cells distributed only 
on the surface; however, this is an artifact of the Beer-Lambert law, 
where the concentration of absorbers was too high.  When rotated, 









Figure 45.  Perfusion culture following HDMEC re-endothelialization with 
improved US/PA processing.  Three injections of 3.3x10
5
 HDMECs, half with gold 
nanoparticles in 3.3 ml media over two hours were delivered to an OA scaffold.  
Cells were allowed to adhere overnight before gradually increasing perfusion flow 
was administered (3.2 dyn/cm
2 
for 24 hours, 8.7 dyn/ cm
2 
for 12 hours, 19.6 dyn/ cm
2 
for 24 hours).  Photoacoustic signal from cells at 750nm indicates the retention of 






Figure 46.  Vascular corrosion casts of re-endothelialized OA scaffolds with HUVECs (A) and HDMECs 
(B) following perfusion culture for 60 hours.  Media was rinsed from scaffolds then fixed before vascular 
corrosion casting performed.  Vascular networks from re-endothelialized scaffolds with HDMECs closely 






presence was observed in both re-endothelialized groups along large vessels that 
normally appear smooth following decellularization (Figure 47).  From a qualitative 
assessment, OA scaffolds re-endothelialized with HDMECs demonstrated capillary 
formations more closely resembling native vascular structures than cell-barren OA 
scaffolds (Figure 46).  HUVECs failed to improve the vascular patency of OA scaffolds 
to the same extent as HDMECs.  In addition, HUVECs aggregated in OA scaffolds more 
than did HDMECs (Figure 48).  Quantitatively, HDMECs had significantly less 
extravasations in each diameter range compared to decellularized scaffolds and were 
statistically indistinguishable from fresh tissue casts in all but extravasations of less than 
10 microns in diameter (Table 2).  In addition, the total extravasational volume of re-
endothelialized scaffolds was much lower than all other decell methods (Figure 49).  Re-






, which was one-and-a-half times 
fresh tissue volume of 1.3x10
5







, a nearly a three-fold increase over re-endothelialized tissue. 
4.3.4 HDMEC Re-endothelialized OA Scaffolds Clear Perfused Blood Compared to 
Barren OA Scaffolds 
Upon harvesting fresh lung, some aggregation of blood could be seen 
macroscopically, however, the tissue was largely blanched allowing for effective analysis 
subsequently (Figure 50).  Following whole-blood perfusion, significant red blood cell 
(RBC) aggregation could be visualized macroscopically in each group, although the 
filling patterns varied drastically (Figure 50).  Initial perfusion into barren OA scaffolds 
was very structured, flowing into a defined vascular space—with various branching; 
however, blood began to rapidly fill the entirety of the scaffold, causing uniform 




Figure 47.  Comparison of large vessels in 
VCCs.  Scanning electron micrographs of fresh 
(A), OA processed (B), and re-endothelialized 
(C) lung tissue.  In fresh and re-endothelialized 
tissues, the larger vessels appear to be 
irregularly formed, denoting cellularity, whereas 
decellularized tissues have smooth vessels.  






Figure 48.  Photographs of re-endothelialized OA scaffolds.  HDMEC (A, C) and HUVEC (B, D) 
cells were injected into decellularized lung then underwent perfusion culture for 60hr using a 
gradually increasing shear stress protocol.  Some cell aggregates were present in the lungs injected 












Table 2.  Extravasation Counts per mm
2
 for Different Decellularization Methods and Re-endothelialization 
 Decellularization Method 
 
Extravasation 
Diameter Fresh OA PSDS POA Re-Endo 
Less than 10 95.26 ± 113.88 4125.19 ± 4978.53* 418.76 ± 541.80† 4494.30 ± 2691.37*‡ 751 ± 872.26*†
Ø
 
10 to 20 24.01 ± 40.96 119.44 ± 11.70* 374.99 ± 474.49* 464.08 ± 425.11*† 25.88 ± 53.16†‡
 Ø
 
20 to 30 3.37 ± 9.80 9.80 ± 19.53 71.78 ± 87.78*† 55.55 ± 65.25*† 11.14 ± 32.06‡
 Ø
 
Greater than 30 3.80 ± 5.88 2.56 ± 10.21 246.28 ± 148.39*† 18.15 ± 23.84*†‡ 1.36 ± 4.29‡
 Ø
 
Asterisk, dagger, double dagger, and ø denote significance (p<0.05) versus fresh, OA, and PSDS, and POA groups respectively 
Table 2.  Extravasation counts following vascular corrosion casting of fresh, decellularized, and HDMEC re-endothelialized lung 
tissue.  Re-endothelialization of OA scaffolds significantly improves the number of extravasations present following VCC.  Re-




Figure 49.  Total extravasation volume was calculated per mm
2
 by cubic micron for each decellularization 
method investigated, as well as re-endothelialized lung.  Re-endothelialization with HDMECs clearly 






































Figure 50.  Photographs of whole blood perfusion into OA 
decellularized scaffolds.  Scaffolds have been re-
endothelialized with HDMECs and undergone 60 hours 
perfusion-culture (A-E), OA decellularized scaffolds (F-H), 
and fresh lung (I-K).  50 ml of blood was perfused into the 
pulmonary artery of the tissue then cleared with 100 ml PBS.  
Although some blood aggregation occurred in fresh tissue (K), 
this was drastically less than in re-endothelialized (C-E), and 
OA decellularized (H).  Whereas blood seemed to pool 
everywhere in OA decellularized tissue (H), in re-
endothelialized tissue, clearing of blood occurred (C-E).  
Image D shows increased clearing of image C when PBS 
perfusion is continued (arrow).  Image E shows the underside 
of the re-endothelialized scaffold has also been remodeled.  
The OA scaffold alone had no regions where blood could be 














Figure 51.  OA scaffolds re-endothelialized with HDMECs help decrease leakage of whole 
blood.  Following re-endothelialization and whole-blood perfusion, scaffolds were perfused 
with PBS to clear blood.  Sections were stained for CD-31 (A, C), staining positively for 
endothelial cells and platelets, and DAPI.  The majority of positive staining for nuclei was 
likely from white blood cells from blood.  Extensive leakage of blood unable to be cleared 
was seen (A, B).  Blood leakage can be visualized in A and B around the top of the vessel 
(demarked with a dashed line).  Although occlusion failed to occur, the resultant leakage can 
be traced.  An overlay with brightfield imaging (B) shows the presence of red blood cells 
(arrow).  C and D demonstrate a working vascular pair.  Some damage in the form of cell 
aggregation can be seen (asterisk) which failed to occur in the regions containing 
nanoparticles (arrowhead).  In contrast, occlusions were present in other vessels present 










the tissue, and took slightly longer to achieve full perfusion.  Re-endothelialized scaffolds 
followed a mixture of the two methods, with the majority of the tissue filling similarly to 
barren OA scaffolds, and a few regions which took slightly longer to become fully 
perfused. 
When perfused with PBS, the distinctions between the experimental groups 
became more evident.  Barren OA scaffolds failed to eliminate the blood that was present 
throughout the entirety of the scaffold.  Fresh tissue became largely blanched, although 
regions of RBC aggregation could be visualized.  Re-endothelialized scaffolds remained 
largely perfused with RBCs; however regions of the tissue cleared over time, suggesting 
cellularity does play a role in the functionality of the vascular patency.  All experimental 
groups achieved clearing of blood in the pulmonary artery and vein. 
Upon sectioning re-endothelialized tissue, staining for CD-31 could be visualized 
extensively (Figure 51).  Although this antibody labels endothelial cells, it also labels 
platelets—which likely encompassed the majority of the positive signal present.  By 
evaluating fluorescence and brightfield images, leakages of the vascular network could be 
seen.  In some of the vascular pairs present, nanoparticles could be seen, and were 
associated with improved vascular performance. 
4.4 CONCLUSIONS 
Implementing a novel imaging technique, we were able to optimize a re-
endothelialization protocol for our scaffold that allowed for cells to penetrate the entirety 
of the construct.  The OA scaffold then served as a vascular substrate for endothelial 
growth to which pulsatile flow could be delivered continuously over 60 hours, which—in 
the case of HDMECs—improved vascular patency demonstrated through vascular 
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corrosion casting methods.  Ultimately this re-endothelialization technique was able to 





Chapter 5:  Discussion 
5.1 INTRODUCTION 
Creating functional de novo vascular networks has become the paramount 
objective of tissue engineering research.  The number of people on the donor list far 
outnumbers the amount of available organs each year.  To help rectify this discrepancy, 
scientists have looked to tissue engineering therapies to help decrease the burden of 
available organs.  However, the most successful tissue engineering products to date have 
been limited to thin (less than 200 µm thick) organs such as tissue or bladder, or 
avascular tissues such as cartilage.  Thicker constructs have failed due to their inability to 
sustain the viability of cells within them.  Without proper nutrient delivery and gas 
exchange, a necrotic core forms instead.  Thick tissue engineering constructs that contain 
a functioning vascular network prior to implantation would be able to sustain cellular 
viability.  Furthermore, creating a scaffold that could be rapidly anastomosed to the host 
vasculature upon implantation would enable rapid nutrient and gas exchange to occur.  
We have explored the use of decellularization to leave behind a vascular architecture 
while removing the cellular material that would present an immunogenic response upon 
implanting the scaffold.  The acellular scaffolds were examined for their ultrastructural 
composition, as well as their vascular functionality, then recellularized to assess the 
subsequent vascular recovery possible. 
5.2 SELECTING VASCULAR TISSUES 
Different organs have been investigated on their potential to improve 
vascularization in vivo.  Specifically, omentum has proven a popular organ because of the 
ease with which it may be harvested, and its high vascularity.  Omentum has been 
decellularized and used as a scaffold to improve vascularization—which has been 
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commercialized into several products; however, this tissue is only several hundred 
microns thick and best suited for smaller vascular patch applications.  Liver and lung 
represented a comparatively thick tissue that was also highly vascularized.  Lung proved 
to be a better selection for our tissue source because of the relative ease to isolate only 
one lobe with a singular vascular axis, facilitating the ability to create an arteriovenous 
loop upon implantation—one of the main objectives of the research.  Furthermore, the 
passive delivery of detergents for decellularization utilized in the OA process was able to 
effectively decellularize lung tissue far more than liver. 
5.3 OPTIMIZED ACELLULAR DECELLULARIZATION OF LUNG 
The OA method developed previously in our lab has proven to be a successful 
means to eliminate cellular material [73].  This method was further investigated on its 
potential to be applied to decellularizing vascular tissue because of its ability to preserve 
the basal lamina of sciatic nerve tissue—whose 5-10 µm lumina diameter are on a similar 
scale to capillaries (2-15 µm).  The segments of lung ranging in thickness (1, 2, 5 mm) 
demonstrated the ability for the OA process to remove cellular material following 
observation of ultrastructural H&E staining.  Even in the smaller segments, the OA 
process was able to preserve an ECM structure that was similar to native tissue.  This 
suggested the ability of this process to be used without damaging the ECM structure on 
the exterior of the tissue—which was more readily perfused with detergents.  The  OA 
process needed modification based on early immunohistochemistry suggesting that 
cellular material was still present at the conclusion of the decell process.  Although 
nucleic material was not seen, the labeling of cellular surface material (the endothelial 
glycoprotein, CD-31) could potentially elicit an immune response upon scaffold 
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implantation.  Subsequently, the decell detergent incubation times were doubled to ensure 
the removal of cellular material. 
5.4 DIFFERENCES IN DECELLULARIZATION TECHNIQUES DIFFICULT TO ELUCIDATE 
USING STANDARD HISTOLOGICAL ANALYSES 
Three decellularization methods were chosen for comparison, OA, PSDS, and 
POA.  These methods were each generally effective in removing cellular material, while 
leaving behind an organized ECM, as demonstrated through histology and 
immunohistochemistry; however, these methods are qualitative and fail to appropriately 
characterize the extent to which the vascular functionality of the tissue is preserved.  
Additional qualitative methods including HPLC analysis are used to measure the amount 
of protein that remains; however, HPLC analysis of decellularized tissue cannot give 
quantitative values because of the cellular control, and offers no insight as to the 
functionality of the remaining ECM. 
The paramount objective of our decellularization methods was to remove the 
immunogenic component of the tissues while keeping the patency of the vascular 
network intact down to the capillary scale.  Such a construct could potentially be used as 
a cell culture system that supports physiological flow in vitro, and could be directly 
anastomosed to the host vascular system upon implantation in vivo—allowing for 
immediate perfusion to the entirety of the graft, and preventing necrotic core formation.  
If damage occurred to the vascular network, the ability to properly perfuse the whole 
graft would be compromised, essentially rendering it a construct with a leaky 
hemorrhagic de novo network.  By utilizing qVCC we would be able to more accurately 
assess the chief function of our scaffold and appropriately award merit to our 
decellularization methods. 
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The decell methods selected were chosen based on successful decellularization of 
other tissues in rat.  Hudson et al. successfully used the amphoteric sulfobetaine 
detergents SB-10 and SB-16, along with the anionic detergent Triton X-200 to preserve 
basal lamina in nerve—the dimensions of which are on similar scale to capillary 
networks [73].  Ott et al. successfully used the anionic detergent SDS along with the 
nonionic detergent Triton X-100 to decellularize heart tissue, subsequently demonstrating 
functionality of the tissue using mechanical testing [76].  In our aim of preserving the 
capillary networks of lung tissue, we focused on optimizing the decellularization protocol 
from the work by Hudson et al. on the thicker, yet less dense lung tissue, while leaving 
the protocol from the Ott study intact.  Although better suited for another tissue source, 
we valued the PSDS method as comparison—as well as an example of results that occur 
when decellularization methods are not properly tailored for their particular application.  
Finally, the POA method was used as another comparison method, investigating the 
gentler detergents of the OA protocol, with the rapid delivery of the PSDS method. 
H&E staining demonstrated that the general architecture was maintained 
following decellularization in each of the decell methods tested.  Some erratic 
hematoxylin was seen in some of the PSDS tissue samples; however the staining was not 
specific to nuclei, and was likely binding to the residual anionic detergent that failed to 
rinse away.  This method utilized SDS, a powerful anionic detergent that commonly 
binds to basal proteins and is difficult to rinse away [117-119].  Although evident when 
looking macroscopically at the decellularized tissues—the decellularized lung from 
perfusion methods were more translucent than from the OA method, suggesting lack of 
cellular material.  Further evidence that residual detergents were responsible for cationic 
staining was confirmed in the quantitative DNA analysis of the tissues following 
decellularization.  Each decellularized scaffold analyzed for DNA content demonstrated 
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significant removal of DNA compared to fresh lung, and in fact, the perfusion methods 
resulted in a larger decrease in DNA content than with the OA method.  Thus the cationic 
agents used to detect anionic residues could only be from the bound anionic detergents. 
The immunohistochemistry analysis performed demonstrated a conservation of 
bioactivity in the ECM proteins stained against in the decell groups comparable to the 
fresh control tissue.  Staining for cellular markers showed an attenuation of signal 
following decellularization compared to the fresh control.  The POA method seemed to 
perform the poorest in this respect, although the technique effectively eliminated nucleic 
material. Using immunohistochemistry techniques alone, decellularization efficacy was 
not immediately evident.  More interesting is how the functionality of the scaffold could 
be further exploited.  To assess this functionality, additional analytical methods were 
needed. 
5.5 QUANTITATIVE VASCULAR CORROSION CASTING EFFECTIVELY DISTINGUISHES 
DIFFERENCES IN VASCULAR PATENCY BETWEEN DIFFERENT ACELLULAR SCAFFOLDS 
Vascular Casts (VC) have been used to image and explore the morphology of 
vascular networks and structures since the 1980s [102, 103]. These permanent 
representations of the vascular luminal space are obtained after the process of perfusing 
the vascular system to remove blood, injecting the vasculature with resin, allowing the 
resin to polymerize, and finally removing the surrounding tissue (Vascular Corrosion 
Casts or VCC), or optically clearing the surrounding tissue. These polymer casts can then 
be used to accurately visualize vascular structures down to the capillary scale.  Scanning 
Electron Microscopy (SEM) and Confocal Microscopy techniques are the most 
commonly used to investigate the vascular structure preserved by the cast due to the high 
resolution images they are able to produce [109, 110].  Ohtake et al. demonstrated the use 
of VCs to elucidate differences in damaged tissues [120].  After evaluating vessel defects, 
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truncations, and extravasation patterns, they found larger extravasations correlated with 
their increased microvascular injury [120].  Our technique aimed to quantitatively 
describe the similarities and differences between the microvascular networks present in 
fresh tissue and following decellularization. 
The cannulation of the OA vascular axis was not a straightforward process and is 
deserving of elaboration.  Initial attempts to cannulate the pulmonary artery required a 
detailed examination of the tissue structure remaining.  The harvested tissue consisted of 
of the pulmonary artery—with its intact bifurcation, a bronchus, and the pulmonary 
vein—consisting of two merged vessels from the lung.  Initial attempts to cannulate the 
tissue included the use of a metal syringe that was inserted in the pulmonary artery past 
its bifurcation.  The transected ends of the pulmonary branches—leading to the heart and 
the right lung—were clamped off.  The resistive force encompassing perfusing the tissue 
proved to be too great for the insertion site of the syringe, and resulted in backflow 
escaping the vessel.  Another problem with the syringe method was the propensity for the 
syringe to puncture the vessel.  The next evolution utilized a rigid 24 gauge cannula to 
prevent punctures from occurring.  Attempts to create a secure connection included the 
use of photocrosslinkable dental resin—which ultimately failed to prevent backflow.  
Finally, a cuffed cannula was created in house using PDMS resin.  This was secured in 
place with a ligation of silk suture placed proximally to prevent slippage of the tissue, 
while also ligating the pulmonary bifurcation—leading to successful cannulation. The 2 
ml/min injection speed was taken from typical injection speeds from literature [121]. 
In characterizing the qVCC data we correlated larger extravasations with greater 
luminal damage.  Given small leaks in the lumina of our vessels, we would expect to see 
smaller extravasations; whereas a larger leak would result in more rapid diffusion out of 
the luminal space and henceforth larger extravasations.  These sentiments are in 
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agreement with previous studies characterizing extravasations in relation to increased, 
manually-induced vascular damage in the brain [120].  From our results the OA method 
resulted in the most small (less than 10 micron) extravasations; however, when counting 
medium (10-30 micron) and large (over 30 microns) extravasations, the perfusion-based 
methods had the most.  When analyzing the total volume of extravasations, we gain a 
clearer insight to the amount of damage present in the vascular network.  Of the decell 
methods tested, the perfusion-based methods had much more total extravasational 
volume when compared to the diffusion-based OA method, and fresh tissue.  When 
performing the qVCC analysis, very little variation in extravasation number and type was 
seen throughout the scaffold of a particular decell method as opposed to comparing 
techniques to each other. 
Differences between VCs of different decell scaffolds could also be seen upon 
macroscopic evaluation.  The colors of the VCs were different—with fresh lung control 
the most white color, and perfusion decell methods containing pinkish hue to them, 
directly correlated the amount of vascular damage in the scaffolds.  The white color seen 
in the fresh VCs was a result of the fine lattice of capillaries that was cast.  The optical 
density of the capillaries would be less due to their small diameters, especially compared 
to the large extravasations seen in the perfusion-based decell methods.  Furthermore, the 
composition of the fresh VC was much more robust, compared to the perfusion-based 
methods—which were primarily a loose composition of extravasations compared to the 
continuous capillary-rich fresh tissue. 
Although unclear at the moment as to the correlation between increased vascular 
ECM damage and subsequent scaffold performance both in vivo, the correlation between 
improved vascular networks and subsequent vascular clearance of blood is a strong 
starting point for improving decellularized vascular tissue.  The importance of a 
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continuous vascular ECM could relate to the role of the ECM in vascularization.  
Following an injury, the vascular basal membrane is first degraded, ECs then proliferate 
and migrate within tissues containing interstitial collagen [63, 64]. Interactions with 
collagen cause a spindle-like morphology that will eventually reorganize into lumina over 
time [65, 66]. The transduction of mechanical forces through the ECM allows ECs to 
establish tension-based guidance pathways, leading to interconnected cords.  Another 
important function of the ECM is to sequester cells. Research has demonstrated that the 
conformation and orientation of fibronectin are key components in EC cell adhesion [68]. 
This important finding, intimates at the importance of being biomimetic not only in 
biochemical composition, but also in spatial architecture. Overall, the ability of 
endothelial ECM to direct EC fate makes scaffold composition a significant characteristic 
to define in a vascular scaffold. 
5.6 OA PROCESSED SCAFFOLDS ARE IMMUNE TOLERATED 
Fischer 344 rats were used as donors to provide isografts and allografts to Fischer 
and Lewis rats respectively.  Left lung lobes from donors were harvested and 
decellularized using the OA process.  These decellularized scaffolds were implanted 
subcutaneously in rats for one or four weeks in either an allograft or isograft model.  The 
one and four week implantation durations were chosen to see different stages in the 
immune response of rats.  In similar implantation studies utilizing ECM scaffolds, the 
onset of the immune response occurs after eight hours [122].  Cellular infiltration is 
common and primarily consists of macrophages and other polymorphonuclear (PMN) 
cells.  After eight days, the PMN cells are gradually replaced with fibroblasts.  In our 
study, the presence of macrophages within the scaffolds after one week was consistent 
between allograft and isograft models, with no appreciable difference.  For every 100 
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cells present, about six were macrophages.  Following implantation for four weeks, the 
scaffolds were extensively remodeled, although fibrous encapsulation occurred.  
Unsurprisingly, the fibrous tissue surrounding the scaffolds contained a higher density of 
macrophages than within the scaffolds—these data were not quantified.  Interestingly, 
histological staining around the bronchus of the OA scaffold after four weeks revealed a 
dramatic increase in cellular infiltration when compared to migration through the exterior 
of the scaffold; however, immunohistochemistry of these regions with increased 
cellularity failed to detect the presence of macrophages.  Macrophage counts between 
within the scaffolds were decreased from the one-week explants, and in fact allografts 
had lower cell counts per nuclei counted than isografts; however, this difference would 
equate to one less macrophage in allografts for every 100 nuclei counted.  The total cell 
counts in the one-week explant demonstrated more cellular infiltration occurred in the 
isograft scaffold; however total cell counts were equivalent after four weeks. 
A positive control depicting an immune response was not used because the 
analysis of immunogenicity in our experiment was performed by counting cells that 
migrated into the scaffold.  If a scaffold that was not decellularized was taken from a 
Lewis rat and implanted into a Fischer rat, then cellular infiltration might not be the same 
as comparing two decellularized scaffolds—which should be more permissive to cellular 
infiltration. 
An analysis of the histocompatibility between the two rat strains suggests a 
positive immune response should occur in Lewis rats, provided the decellularization 











 to be the major histocompatibility complexes in 









[124].  Two of the histocompatibility complexes are identical, however there are six 
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differences, indicating an immune response would be expected given a lack of 
histocompatibility.  Thus, the OA method was effective in removing immunogenic 
components as verified by the similarities in the explants between the two groups. 
In a tangential finding, subcutaneously implanted scaffolds were able to support 
the viability of cells in the entirety of the explant.  This explant was remodeled into a 
uniform round disc after four weeks in vivo but still retained significant amount of 
volume (approximately 1-2 cm in diameter).  Immunohistochemistry targeting the 
endothelial glycoprotein CD-31 was present throughout the explant, and was more 
prevalent than macrophage cells (Appendix).  This finding was surprising, considering a 
fibrous capsule formed around all the scaffolds.  This finding points at the capacity for 
cellular ingrowth utilizing this scaffold. 
5.7 ULTRASOUND GUIDED PHOTOACOUSTIC IMAGING IS AN EFFECTIVE TOOL TO 
DISPLAY CELLULAR DISTRIBUTION 
The technique of US/PA imaging has been pioneered by researchers at The 
University of Texas at Austin.  Drs. Stanislav Emelianov and Laura Suggs have 
implemented this technique with the end goal of tracking cells delivered in vivo.  
Although many complications regarding cellular interactions, nanoparticle retention and 
expulsion, and subsequent nanoparticle uptake by other cells remain obstacles to 
translating this technique in vivo, the applications of US/PA imaging in vitro are 
attractive. 
Previous research utilizing this technique has demonstrated the capacity for 
hMSCs cultured with the same gold nanotracers to maintain viability and engage in the 
same phenotypic changes observed without nanotracers—when being cultured in 
different 3-dimensional matrices.  These cells were differentiated using PEGylated fibrin 
gels as previously described [125].  Briefly, hMSCs (Cambrex, East Rutherford, NJ) were 
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cultured for one week in serum-containing MSCBM medium (Cambrex) supplemented 
with MSCGM SingleQuots (Cambrex) prior to gel seeding at 5x10
4
 cells/ml, fibrinogen 
at 10 mg/ml, thrombin at 12.5 U/ml, and difunctional SC-PEG (succinimidyl carbonate, 
3400 Da, Sunbio, Anyang City, South Korea) at a 10:1 molar ratio to fibrinogen.  After 
seven days of culture in vitro the photoacoustic signal was still present, although 
somewhat attenuated due to cell division and exocytosis.  These cell-seeded gels were 
also maintained for 10 days in a rat hind limb implantation model, with signal present at 
the conclusion of the study [126].  With these studies already published, the concept of 
using US/PA imaging to track the distribution and retention of cells within the OA 
scaffold was promising.  This technique allows for specific detection of localized 
nanotracers due to plasmon resonance resulting in a red-shifted peak broadening of light 
absorption by aggregated nanotracers. 
5.7.1 Cellular Uptake of Nanotracers Does Not Alter Cell Fate 
Cellular uptake and subsequent behavior was of paramount importance in order 
for US/PA to be a plausible method for observing cellular distribution subsequently.  We 
initially chose a seeding density that was comparable to previous studies in our 
department that utilized mesenchymal and adipose-derived stem cells.  Following 24 
hours of incubation, nanoparticles were readily taken up by both endothelial cell lines 
used as verified through brightfield and darkfield imaging.  After expanding these cells 
out to confluency, general morphological characteristics were consistent with endothelial 
cells.  Both HDMEC and HUVEC cells took on a cobblestone-like morphology in phase 
contrast images. 
The results of the MTS assay revealed the inert qualities of the nanotracers when 
taken up by cells.  Although there was a significant difference between HUVECs 
monitored 24 hours following the addition of nanoparticles (p<0.01), the difference in 
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observed MTS fluorescence intensity at 490 nm for cells cultured with nanoparticles was 
only 15% less than intensity observed in cells cultured without nanoparticles.  
Furthermore, when cells were expanded out for an additional two days, the MTS activity 
was equivalent between cells with and without nanotracers having been added.  MTS 
activity in HDMECs was also equivalent in 24 and 72 hour culture conditions, suggesting 
the inert influence of nanotracers on the cells. 
5.7.2 US/PA Imaging Effective at Detecting Cellular Distribution in OA Scaffolds 
Whereas researchers in the past used histological sectioning to investigate the 
distribution of cells implanted into decellularized tissues [18-20, 76, 117, 119], we 
utilized a technique that could accurately map the distribution of cells throughout the 
entirety of the scaffold, without reconstructing a series of physical tissue sections.  In 
selecting this method we were able to at-once visualize cells, enabling greater ease in 
optimizing re-endothelialization parameters, as well as communicating the data through 
transparent publishing—opposed to selecting one “representative image.” 
US/PA imaging demonstrated differences in cellular distribution depending on 
injection density, as well as periodicity.  Upon injecting cells containing nanotracers in 
the OA scaffold, it was important to verify that the PA signal detected was only from the 
nanotracers in the cells, and not loose systemic nanoparticles that might have been 
exocytosed.  An initial injection of nanoparticles alone was used to verify that PA signal 
was not present from nanoparticles alone; however, PA signal was detected close to the 
site of injection, although not in the larger vessels comprising the scaffold’s vascular 
axis.  This distinction was likely a result of nanotracer aggregation in the capillary beds 
within the scaffold.  The ability to plug the capillaries using small microparticles has 
been performed by researchers attempting to obtain VCCs depicting the larger vessel 
structure of the tissue, without obstruction from the dense capillary beds [127].  Plugging 
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the capillaries would allow for subsequent nanotracer aggregation and the red-shifted 
plasmon resonance frequency to be detected.  This study highlighted the importance of 
optimizing the injection parameters to allow for broad cellular distribution without 
plugging the capillary beds. 
An injection schedule was then implemented that allowed for broad distribution 




 cells/ml did not 
aggregate in capillaries; however, when increasing the number of cells, the subsequent 
injections needed to be split into a series of smaller injections in order to prevent 
aggregation of cells within capillaries. 
Once injected within the scaffolds, the ECs with nanotracers were able to be 
imaged upon injection and at the conclusion of the study with US/PA imaging, 
demonstrating cellular distribution.  Cells were able to penetrate throughout the entirety 
of the scaffold, and were maintained despite the addition of physiological shear flow.  
Cross-sections of the US/PA imaging demonstrated that the cells were not present in the 
bronchus, further indicating the patency of the vascular network that remained, as well as 
the efficacy for the technique to visualize cells on a relevant spatial resolution.  
Histological evaluation further demonstrated that nanoparticles were contained within the 
cells.  Although some free nanoparticles existed and cells can freely exocytose them, 
these nanotracers will not be detected by the 750 nm laser because they are not 
aggregated and hence will not present plasmon resonance. 
A complication that occurred when using US/PA imaging following the injection 
of cells was utilizing too many nanoparticles.  The increase in photoacoustic absorbers 
prevented the penetration of light in the scaffold as depth was increased.  This resulted in 
no signal in the re-endothelialized scaffolds when moving away from the photoacoustic 
laser.  According to the Beer-Lambert law (eq. 2) there were two ways to increase the 
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penetration depth.  In order to fully penetrate the scaffold, the sensitivity had to be 
decreased according to the Beer-Lambert law (eq. 2).  Where δ is the penetration (cm), σ 
is the absorption cross section (cm
2






To allow for greater penetration, we chose to leave the absorption cross section 
the same, while decreasing the number of absorbers—by using nanoparticle-loaded cells 
in only one of the three injections when re-endothelializing the tissue.  This effectively 
solved the penetration problem. 
Although uniform distribution could be visualized through US/PA imaging, and 
cells could be found throughout the scaffold sections, at the cellular level the entirety of 
the scaffold was not cellularized.  Brightfield imaging revealed the presence of cells in 
the locations of nuclei visualized fluorescently; however although a minority, there were 
also nanoparticles present which were not associated with nuclei but were positive for 
CD-31 markers.  Whereas the US/PA imaging was able to accurately reflect the 
distribution of cells within the scaffold, histological analyses are still needed to refine the 
total number of cells that can be permitted into the tissue. 
5.8 RE-ENDOTHELIALIZATION AND PERFUSION-CULTURE WITH HDMECS IMPROVES 
VASCULAR PATENCY 
The perfusion of cells into the scaffolds was performed as described above.  The 
subsequent perfusion-culture was based off beneficial effects of shear flow on endothelial 
cells once anastomosed to the host vasculature (the end goal of this scaffold).  Inoguchi et 
al., found that a shear stress regimen of 24 hours 3.2 dyn/cm
2
, followed by 8.7 dyn/cm
2
 
   
 
  
  (eq. 2) 
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for 12 hours, and finally 19.6 dyn/cm
2
 for 24 hours significantly conditioned the 
phenotype of endothelial cells in a large vessel setup [35]. 
5.8.1 Perfusion Set-up and Shear Calculations 
To determine the shear stress on our cells, we used the Hagen-Poiseuille equation 
(eq. 1). Our perfusion system was more complex and consequently we needed to first 
determine what diameter to select as the diameter to base our calculations on.  Since 
Inoguchi et al. implemented their shear stress regimen on large vessel—we looked at the 
largest vessel that was being cannulated as our starting diameter.  The pulmonary artery 
of the Fischer rats at the age we harvested was measured to be around 0.5 mm at the point 
of cannulation, and was thus used as the diameter moving forward.  The dynamic 
viscosity was based off the Inoguchi et al. study in which the media was found to have 
viscosity of 0.0075 dyn∙s/cm
2
.  The flow rate was then determined that would result in the 
desired shear stress, which was then converted into pump-head rotations per minute—the 
control display for the iPump peristaltic pump we used. 
The full perfusion of the lung was necessary to culture cells that span the entirety 





 = 28-36 ml/min) [128].  This gave us a large target window that would 
allow for perfusion to occur.  After a thorough literature search on right ventricle 
pressure, it was determined that the typical pressure for rat lung perfusion are generally 
between 5-18 mmHg for diastolic and 12-30 mmHg for systolic pressures for rats varying 
in weight and sex, but higher pressures can be tolerated [129-132].  Even at low flow 
rates, our pump was able to deliver more than enough pressure to fully perfuse the lung.  
As our system was open, the amount of pressure delivered to the scaffold could not be 
controlled, and was dependent on the resistive load of the tissue; however, full perfusion 
in all injection studies was seen, without damage to the major vessels of the scaffold. 
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Sterilization of the decellularized scaffold was a major challenge when attempting 
to perform the in vitro cell experiments.  This has been an issue with using ECM-derived 
constructs in medicine.  Standard sterilization methods such as ethylene oxide, peracetic 
acid, and gamma or e-beam radiation have all been used to sterilize ECM derivatives 
with differing levels of success in terms of efficacy and ECM preservation [133-136].  
Although some damage has been seen following e-beam sterilization [133-135], typically 
involving partial denaturation of collagen, literature exists that demonstrates irradiation 
causes insignificant effects on ECM biochemistry and cellular affinity [136].  We used e-
beam irradiation to successfully sterilize the scaffolds.  This process had no visable effect 
on subsequent VCC and perfusion-culture studies; however, alternative methods such as 
supercritical carbon dioxide might be an alternative method for sterilizing ECM [137]. 
5.8.2 Vascular Patency Determination 
Vascular patency of OA scaffolds following re-endothelialization with HDMECs 
(Rd-OA) outperformed barren OA scaffolds, as well as scaffolds re-endothelialized with 
HUVECs (Rv-OA).  The differences were noticeable from the US/PA images acquired.  
PA signal was more clustered in Rv-OA than with Rd-OA scaffolds.  This clustering was 
likely a result of aggregation in the capillary beds which in turn effected the perfusion of 
Mercox resin in the scaffold.  A reason for this could be the relative size of the cells—
with HDMECs being approximately half the size of HUVECs. 
From a qualitative assessment of the VCCs, the Rd-OA scaffolds contained 
capillary architectures that resembled native tissue.  These are slightly irregular capillary 
meshes, having non uniform diameters within the mesh.  This is in contrast with Rv-OA 
scaffolds and the barren OA scaffolds, which had uniform tubular vessels. 
Quantitative analysis of the VCCs substantiated the qualitative observations.  Rd-
OA scaffolds contained far less extravasations than barren OA scaffolds in all diameter 
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subgroups that were inferior from fresh tissue, and were indistinguishable from fresh 
tissue in all but extravasations of less than 10 microns in diameter.  As discussed earlier, 
the number of extravasations correlates to an increase in damage to the patency of the 
vascular network.  The total extravasational volume from Rd-OA scaffolds was much 
less than the barren scaffolds and pointed to the superiority of the vascular structure after 
re-endothelialization. 
CD-31 positive staining using immunohistochemistry demonstrated the presence 
and activity of the cells that remained in the scaffold following perfusion culture.  VE-
cadherin staining was not as strong.  The fact that cells persisted in the tissue along 
vessels even when physiological shear stress was applied points to the viability of the 
cells within the tissue.  Dead cells would not be attached to the ECM, especially under 
stress.  Although cells were present in most of the sections imaged using bright field 
fluorescence microscopy, the numbers were far less than what would be seen in fresh 
tissue.  Further investigation would be needed to find how many injections could be 
possible to increase cell numbers. 
5.9 IMPROVED VASCULAR PATENCY IMPROVES CLEARANCE OF BLOOD IN 
DECELLULARIZED SCAFFOLDS 
The same perfusion-culture system was again used to perfuse blood throughout 
the lung.  In this setup, the kinematic viscosity was changed to that of blood (estimated to 
be between 0.03-0.04 Poise at 37
o
C [138].  An additional consideration was the shear rate 
being applied to the blood through our system.  To be considered Newtonian, blood shear 
rate must be over 100
-s
 [139].  We also wanted to prevent hemolysis that might result 
from too high a shear coming from the cannula.  Podgoreanu et al., utilized a peristaltic 
pump to implement a successful bypass in a rat model [140].  They used an average flow 




 (similar to the normal cardiac output of rats), along with a 
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20-gauge cannula injected into the tail vein to perfuse animals for 60 min.  We calculated 
the shear rate for their setup again using the Hagen-Poiseuille equation (eq. 3), assuming 
a 350g weight which was the average range of the animals they used. 
 
 
The shear rate was found to be 46069.54
-s
.  This value was then applied to our setup as a 
maximum value.  We were able to use equations 1 and 3 to determine the associated 
shear stress, and then calculate the necessary flow rate given our radius of 0.0155 cm for 
the 24-gauge needle we use for our perfusions.  It was then determined what flow rate we 
needed so as not to surpass this shear rate, depending on what the tubing length was (8.1 
ml/min).  We used a flow rate of 5.8 ml/min which had a shear rate of 32685.8
-s
 at the 
cannula and 983.19
-s
 at the vessel entrance.  The shear stress was slightly higher than 
what we perfused into the construct using media at 23.75 dyn/cm
2




 Following whole-blood perfusion, we were able to visualize repeatable 
differences between fresh tissue, barren OA scaffolds, and re-endothelialized OA 
scaffolds.  The purpose of this study was to correlate the improved vascular patency 
determined through qVCC analysis with a physiological response.  A flaw in this system 
is that the cause for blood aggregation is not understood absolutely.  Aggregation of 
blood could be a result of clotting in vessels or simply pooling in the interstitial space 
outside the vascular network.  In addition, the fresh rat tissue harvested was perfused with 
the same human whole-blood as the other scaffolds.  This xenogeneic transfusion could 
result in an immune response, which could also explain the aggregation that occurred in 
fresh tissue.  Despite these uncertainties, we believe clearing the tissues with PBS helped 
to visualize deficiencies in the vascular network regardless of the case.  Vascular 





   
 (eq. 3) 
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performance was particularly evident when comparing re-endothelialized scaffolds with 
barren OA scaffolds.  Although vascular and capillary-like structures existed in the VCC 
of barren OA scaffolds, extravasations did exist, and were likely the cause of blood 
pooling in the interstitial space.  This pooling was also seen in re-endothelialized 
scaffolds; however clearing of some of blood from regions of the scaffold was also 
demonstrated.  This clearing most commonly occurred along the major vessels of the 
scaffold, and extended to the lower portion of the scaffold—following the pulmonary 
vein.  In all experimental groups, the vascular axis became cleared of blood—
demonstrating that some vascular integrity remained. Histological techniques showed the 
presence of vascular leakage which occurred in vascular pairs.  Positive CD-31 staining 
depicting platelet presence was more evident in regions where clotting and leakage 
occurred.  Brightfield imaging was helpful in finding regions of re-endothelialized cells, 
as wells as the presence of red blood cells.  In areas where nanoparticles were visualized 
in brightfield imaging, there was a decrease in platelets and leakage, hinting at the 
importance of endothelial cells in this capacity. 
The inability to clear blood from the decellularized tissue provides insight as to 
why the perfusion-based decellularization methods failed to remove some biological 
components (in the case of CD-31 in POA processed tissue) as well as residual detergent.  
In these methods, after creating damage to the vascular network, detergent solution would 
likely pool in regions, much the way blood did in OA and even re-endothelialized tissue, 
and would remain there despite rinsing with buffer.  Alternatively the OA process allows 
for flux and clearing throughout the entire tissue, enabling rinsing despite damage that 
occurred to the vascular network. 
Further experiments investigating the dynamics between cells, vascular patency, 
and physiological performance will need to be performed to optimize the various 
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parameters to the end goal.  We have laid the foundation establishing a connection 




Chapter 6:  Conclusions and Future Directions 
The purpose of this dissertation was to describe the motivation and development 
of a decellularized vascular scaffold.  We outlined a method for effectively 
decellularizing lung tissue with a series of chemical detergents, while retaining most of 
the native architecture and patency of the vascular network down to the capillary scale.  
Such a scaffold was able to support cellular growth via injection loading and perfusion 
culture for three days—which in turn allowed cells to form capillary meshes and recover 
the vascular patency of the tissue. 
The optimized acellular method was compared against two other decell methods.  
The first was taken from a method to decellularize heart tissue.  The second was a 
method that utilized the detergents from the optimized acellular method, but delivered 
them in a perfusion system.  Following decellularization, each tissue was examined on its 
ability to remove cellular components while retaining the architecture of native lung—
particularly as it pertains to its vascular network.  Standard characterization methods 
including histology, DNA concentration, and immunohistochemistry failed to elucidate 
significant differences in the efficacy of the decell methods.  Functionality-based 
characterization using vascular corrosion casting was necessary to demonstrate the 
superiority of the optimized acellular method over the others tested.  Qualitative electron 
micrographs depicted capillary-like structures that were not present in the corrosion casts 
of the other methods.  Quantitative analysis of the electron micrographs was used to 
determine how much resin leaked out of the vascular networks in the form of spherical 
extravasations.  Counting the total extravasational volume demonstrated the superiority 
of the optimized acellular method over the other two decellularization methods chosen, 
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and highlighted the importance of functional characterization when evaluating 
decellularization protocols. 
Re-endothelialization of the vascular network remaining in OA scaffolds was 
investigated by first determining the proper injection concentrations needed to attain 
uniform cellular distribution, then evaluating the vascular patency using qVCC analysis.  
An injection protocol was established that allowed for consistent loading and uniform 
distribution of cells into the vasculature of the OA scaffolds.  After 60 hours of applied 
shear stress, the vascular patency proved to be improved when compared to barren OA 
scaffolds.  The capillary-like structures that were present in the decellularized scaffolds 
were restored to resemble actual capillary structures once human dermal endothelial 
microvascular cells were added.  The re-endothelialization also decreased the amount of 
extravasations and total extravasational volume.  Following perfusion with whole blood, 
this improved vascular patency enhanced the ability to clear blood following perfusion 
with PBS, compared to barren scaffolds alone.  Although some pooling of blood in the 
re-endothelialized construct was still observed, a correlation between improved vascular 
patency upon re-endothelialization and ability to perfuse and clear blood can be 
established.  What needs to be determined is what significance the improved vascular 
patency will have on subsequent scaffold performance when implanted in vivo.  The 
ultimate goal was to create a tissue engineering construct that could be potentially 
anastomosed to the host vasculature to allow for rapid perfusion to the entirety of the 
construct, in this regard the performance will be directly related the ability for the 
construct to facilitate blood flow without hemorrhaging.  A hemorrhagic area would 
inevitably lead to poor nutrient transport and likely cell death in that area.  A detailed 
study that looks at in vivo vascular performance would be necessary to draw the 
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appropriate connections between vascular patency in vitro and subsequent performance—
enabling the tailoring of future constructs to be properly optimized in vitro. 
Further work needs to be performed to improve the vasculature of re-
endothelialized scaffolds.  Although we demonstrated regions of tissue that could be 
cleared following perfusion with blood, there were still regions of the scaffold that failed 
to clear.  A more detailed investigation on the re-endothelialization process specific to the 
number of cells needed to effectively reconstitute the scaffold should be performed.  
Following optimized re-endothelialization, the next step to creating a relevant tissue 
engineering construct will be to observe the ability for the construct to support tissue-
specific cells.  Creating a patent vascular network will allow for the efficient flux of 
nutrients throughout the tissue, what needs to be understood is what happens to the cells 
in the remainder of the ECM not comprising vascular networks.  Future studies could 
include implanting different cell populations into the bronchial space, allowing for 
additional repopulation of the scaffold prior to implantation in vivo. 
Creating a co-culture system to support tissue-specific cells could be established 
using our re-endothelialized scaffold.  Various researchers have used culture systems to 
support adult stem cells in a tissue-specific manner by tuning the modulus of the substrate 
in 2D [141] and 3D [142, 143].  Along these lines, the capacity to surround the vascular 
space created following re-endothelialization with a hydrogel of a specific modulus could 
be performed. 
Using a hydrogel with a modulus that supports MSC differentiation toward 
adipose tissue could be a potential therapy for partial mastectomy healing.  Scaffolds 
implanted in regions of adipose tissue experience greater vascularization than 
subcutaneous regions [144].  Included in the appendix section of this dissertation are 
images of sectioned explanted OA scaffolds following four weeks subcutaneous 
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implantation. These images contain high positive staining for CD-31, demonstrating 
abundant vascular ingrowth.  Such results may point to the ability of this scaffold to 
support vascularization without the need for anastomosis—again suggesting adipose 
implantation could lead to vascular ingrowth and support of MSCs comprising the 
majority of the tissue.  Preliminary work on this project could consist of implanting re-
endothelialized scaffolds subcutaneously into the right flank of rats, to observe the 
relative vascularization found in decellularized scaffolds alone.  Creating an OA scaffold-
hydrogel combination could also be performed preliminarily to observe the ability to 
support the viability of MSCs alone, or MSCs in a re-endothelialized scaffold.  
Researchers have demonstrated the ability to re-endothelialize decellularized lung tissue 
using the bronchial space instead of vascular space [145, 146].  Following re-
endothelialization using our system, a second cell type or gel could easily be delivered by 
injecting the bronchus.  This would allow for a controlled filling of the remaining space 
within the OA scaffold. 
The majority of literature describing tuning PEG matrix stiffness to direct stem 
cell differentiation has been performed to isolate the effect stiffness has on cells without 
the influence of biological factors.  In a concurrent project devised with the aid of 
funding from the venture capital group Remeditex, we have demonstrated the ability to 
create injectable gels from reconstituted decellularized matrix.  Following the 
decellularization process, we are able to regel the ECM after mechanical and enzymatic 
degradation.  The stiffness of this injectable ECM hydrogel is tunable depending on the 
solution used to regel (Appendix).  A tissue engineering scaffold could potentially be 
created using the re-endothelialized matrix along with regelled ECM—specific to a 
particular tissue, and having an elastic modulus that could better support cells in that 
region. 
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Although the primary focus of this research has been to create a tissue 
engineering construct, other potential applications have presented themselves through the 
work performed here, as well as through interactions with other researchers and other 
literature.  The composition of the scaffold used here is biomimetic, both spatially and 
chemically.  With such considerations in place, the scaffold presents itself as a potential 
bioreactor system to investigate cellular phenomena, and drug-cell interactions.  The 
effect that architecture might have on stem cell differentiation is one possible 
investigation.  More research is being published focusing on the composition of the 
extracellular matrix on stem cell differentiation and “renewal,” [147, 148] and the use of 
this scaffold would add to this field of investigation. 
Problems finding an in vitro system to monitor effects of drugs on cells are in part 
due to the simplicity of systems in vitro opposed to the complexity of systems in vivo.  
With increasing research demonstrating the difference between cellular fate in 2D and 
3D, it would make sense that the 3D environment plays an important role in the 
determination of cell fate—which would in turn affect drug response.  Although this 
system would be extremely low-throughput, it nevertheless could be a helpful late stage 
in vitro tool that allows for greater control than in vivo models.  Although this system has 
been used solely on the left lung lobe, the entire cardiovascular system could be easily 
decellularized, with little fear of excessive damage to the extracellular matrix based on 
the decellularization of 1 mm thick sections of lung being equivalent to 5 mm thick 
sections. 
In conclusion, we created a decellularized scaffold that included a patent vascular 
network confirmed by augmenting standard characterization methods with the functional 
characterization.  This decellularized scaffold was immune-tolerated and supported 
cellular growth of endothelial cells while implanted.  The scaffold allowed for perfusion-
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based culture of endothelial cells—which imparted an improved vascular patency to the 
scaffold.  We also applied a novel imaging modality that allowed us to monitor the 
loading of cells in a complex manner—enabling optimization that likely could not have 
occurred otherwise.  Although not functionally relevant at this time, we propose this 




Appendix A:  Left Lung Isolation Protocol 
 
Procedure: 
1. Remove the esophagus from the dorsal side 
2. Transect lymph tissue and descending aorta in between the esophagus and the left 
lung 
3. Flip lung over to expose the ventral side 
4. Completely remove the thymus 
5. Clear lymph tissue above and around the aortic arch, until it becomes an 
impediment 
6. Transect the aorta as close to the heart as possible—lift the tissue and cut the 
vessel free from connective tissue 
7. Clear away lymph tissue to expose the right pulmonary artery distal to the 
bifurcation 
8. Transect the right pulmonary artery as close to the right lung as possible—again, 
lift the tissue and cut the vessel free from connective tissue 
9. Transect the trachea distal to the bifurcation 
10. Transect the pulmonary artery as close to the heart as possible—lift up and cut to 
free the vessel, then fold the vessel over the left lung 
11. Separate the left lung from the heart to expose the pulmonary veins (brownish in 
color), then transect them 
12. Remove any connective tissue to free the left lung from the heart 
13. Finish by removing excess fat and lymph tissue 
 
The artery should be underneath the trachea, which is underneath the vein 
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Appendix B:  Hematoxylin and Eosin Staining 
Solutions: 
Eosin-Y 
100 ml 1% eosin solution 
300 ml EtOH 





10 g Magnesium sulfate 
2 g Sodium bicarbonate 




Procedure: (Frozen Slides) 
1. Thaw slides 
2. Rinse with water 
a. Hematoxylin for 2 min 
b. Tap water 2 changes 5 dips 
c. Scott solution dip until blue 
d. Tap water 2 changes 10 dips 
e. Eosin 15 dips 
f. 95% EtOH 10-15 dips 
g. 100% EtOH 10-15 dips 
h. 100% xylene 3 changes 10-15 dips 
3. Permount and mount coverslip 




Appendix C:  Vascular Corrosion Casting Protocol 
Materials: 
Mercox II CL-2R 
40% Benzoyl peroxide 
Syringe pump with appropriate tubing 
Modified 21Ga cannula (silicon rubber bead added) 
Suture 
 
Procedure:  Casting 
1. Using stereoscope, insert modified cannula (needle removed) into the pulmonary 
artery of the left lung—note:  inject the cannula with PBS prior to insertion 
2. Use chromic suture to tie a knot around the pulmonary artery—note:  fold the 
right pulmonary artery such that the knot ties off the branching vessel as well 
3. Attach the cannula to a luer plug attachment on tubing—note:  tubing should be 
filled with PBS 
4. Without creating bubbles, carefully mix Mercox II resin with 40% benzoyl 
peroxide (0.2 g catalyst/10 mL resin) and draw into a syringe while in the 
chemical hood 
5. Attach tubing to syringe and perfuse tissue with the resin at a rate of 2 mL/min 
6. Allow polymerization to occur in the hood for 10 min then cut cannula off the 
tissue and place the lung into a 15 mL conical tube filled with water 
7. Place the conical tube in a water bath at 55-65oC for 1-2 days 
 
Procedure:  Tissue maceration 
1. Place tissue in 25% KOH and place on a plate-shaker for 3-10 days 
2. Every two days use water bath to help clear tissue, and change KOH solution 
3. Place tissue in desiccator for SEM prep 
 
Use glass in all resin polymerization steps.  Once polymerized, the plastic can be easily 
removed.  Once polymerized, the cast is no longer a health concern. 
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Appendix D:  HPLC Analysis 
HPLC Analysis of OA Decellularized Tissue 
Another method used to characterize the biochemical composition of a particular 
material is high-performance liquid chromatography (HPLC).  OA Processed lungs were 
degraded by flash-freezing, then grinding with a mortar and pestle.  Enzymatic 
degradation of proteins was achieved by using pepsin at a pH of 2, and then neutralized 
after degradation was complete.  Samples were electrophoresed on a 4-20% precast 
polyacrylamide gel.  A trypsin-in-gel sample digestion (20 µL/sample) protocol was used 
before extraction with 5% formic acid in HPLC water.  Samples were then processed 
using mass spectrometry HPLC in the Core Facility in ICMB. 
HPLC Analysis Confirms Qualitative Composition of ECM Following OA 
Decellularization 
Protein and tissue composition following decellularization was compared to fresh 
tissue.  Although quantitative compared to the baseline sample, the actual protein 
concentrations obtained could not be absolutely quantified, only relatively quantified.  
All decell methods had similar relative distributions of proteins, which were consistent 
with fresh lung tissue (Table, Figure). 
In lung decellularized using the OA procedure, fibrillin-1 comprised the majority 
of protein left in the ECM with 88 spectrum counts.  This is not surprising based on the 
high amount of elasticity exhibited by both fresh lung as well as the decellularized 
scaffolds.  With 41 spectrum counts, the next most prominent protein was laminin 
subunit β2, a common component of vascular smooth muscle ECM.  The next most 
abundant protein, with 28 spectrum counts, was laminin subunit α5, a major component 
of basement membranes which has a high affinity with integrin α3β1.  This was followed 
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by the interstitial matrix protein collagen type VI at 24 spectrum counts.  The most 
prominent proteins were by far fibrillin followed by various laminin subunits.  Only two 
collagens featured prominently, collagen type VI and collagen type IV(α2), at 24 and 14 
spectrum counts respectively.  Other proteins present included collagen type I, elastin, 
fibronectin and nidogen.  In summary, 41% of the proteins found belonged to laminin, 
34% to fibrillin, 21% to collagen, 2% to elastin, and 1% to fibronectin. 
HPLC analysis of our decellularized tissue allowed for the presence of a vast 
array of proteins to be observed.  Although this method is not purely quantitative, it did 
allow for relative distributions of proteins within the different experimental groups to be 
compared.  Following decellularization using the OA procedure, the majority of proteins 
identified were fibrillin-1, followed by various laminins.  Fibrillin-1 is a glycoprotein that 
is responsible for forming microfibrils that surround elastin in the ECM.  Given the high 
degree of elasticity in lung a high presence of fibrillin-1 is unsurprising.  Laminin subunit 
β2 is a component of laminin-9, an endothelial cell basement membrane [61].  This 
laminin plays a role in endothelial cells stabilization [61].  Laminin subunit α5 is 
commonly found in laminin-5, laminin-10 (adult and vascular basement membranes), and 
laminin-11 (endothelial cell basement membrane) [61].  This subunit has a high affinity 
for the α3β1 integrin—upregulation of this binding has been shown to drive stabilization 
of the endothelium, ceasing proliferation and migration of endothelial cells [61].  The 
most prevalent collagen fragment found was collagen VI(α3).  Collagen VI has 
significant interactions regarding endothelial cells.   This interstitial protein helps 
organize ECM components through its binding of collagen types I, IV, and VIII [61].  
Not all proteins were involved solely in stabilization of endothelium.  Some collagen type 
IV was present (sixth highest protein count).  Although this accessory protein of 
basement membrane assembly helps stabilize the basement matrix under stress, it is also 
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involved in endothelial cell tube formation [61].  The presence of these major 
components tends to point at the preservation of basal membranes upon decellularization, 
with less interstitial proteins and less fibronectin and collagens.  An interesting 
component present was nidogen-1, an accessory component to basement matrix assembly 
that also enhances endothelial tube formation [61].  HPLC analysis allowed for a wide 
selection of ECM proteins to be observed, however the presence of these proteins could 







 HPLC Protein Analysis of Lung Tissue Following OA Decellularization 
Proteins                               Spectrum Counts (%) 
  OA   
Collagen Type I (α1)  3.1   
Collagen Type II (α1)  1.2   
Collagen Type IV(α2)  5.4   
Collagen Type VI (α1)  1.5   
Collagen type VI (α2)  0.8   
Collagen Type VI (α3)  9.2   
Total collagen  21.2   
Elastin (iso 2)  1.9   
Fibrillin-1  34.0   
Fibronectin (iso 2)  1.2   
Laminin (α5)  10.8   
Laminin (β2)  15.8   
Laminin (β3)  3.9   
Laminin (γ1)  8.1   
Laminin (γ2)  2.3   
Total Laminin  40.9   






HPLC analysis reveals conservation of proteins following decellularization.  OA tissue contained a high level 






Number of spectrum counts for various proteins in lung following OA processing.  
HPLC analysis reveals a majority of fibrillin along with laminin and some collagens. 











Adapted from ICMB Core Facilities 
 
This protocol was developed for 2D gel spots, ~100ng, using Dilution A of 
trypsin for silver, sypro ruby or faint Coomassie stained bands. If Coomassie stained 
spots at ug levels (medium to dark) are being digested, use Dilution B for trypsin 
aliquots. 
Be ultraclean in all steps prior Day 3 step 1. If any keratin from dust or skin gets 
into the sample from the gel, cutting surface, pipette tips, tubes or digestion buffer, it will 
show up in the mass spectra and swamp weaker signals from the protein. Use tubes and 
tips that have not been exposed to ungloved hands. If possible work in the hood or a clean 
bench and filter the solutions, keep all the materials in an area dedicated to in-gel 
digestion. Wear lab coat and keep hair covered and held back. 
 
Solutions: 
1. Destain (400uL/sample) 
- 50% Methanol, 5% Acetic Acid in HPLC water 
2. Trypsin (20uL/sample)  
- Add 160uL of Trypsin buffer to Trypsin stock solution tube (40uL of 
0.5ug/uL). Then make aliquots of 20uL (2ug of Trypsin) and store in the 
freezer. 
- Prepare a fresh solution from aliquot before use. 
- Dilution A: 180uL of 50mM Ammonium Bicarbonate to each vial of 2ug 
(Promega) sequencing grade Trypsin. (Final concentration: 10ug/mL = 
10ng/uL). 200 uL per vial 
3. Acetonitrile (600uL/sample) 
4. 10mM DTT (100uL/sample) 
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- Prepare a fresh solution before use. 
- 1.54mg of DTT in 1mL of 100mM Ammonium Bicarbonate 
5. 50mM Iodoacetamide (100uL/sample) 
- Prepare a fresh solution before use. 
- 10mg of Iodoacetamide in 1mL 100mM Ammonium Bicarbonate 
6. 100mM Ammonium Bicarbonate (200uL/sample) 
- 0.79g of Ammonium Bicarbonate in 100mL of HPLC Water (Filtered with 
0.2um syringe filter) 
Note: Also add amount needed to make 50mM Ammonium Bicarbonate, 10 mM DTT and 
50mM    
          Iodoacetamide solutions. 
7. 50mM Ammonium Bicarbonate (20uL/sample) 
- Dilution 1:1 of HPLC Water:100mM Ammonium Bicarbonate 
Note: Also add amount needed to make Trypsin solution. 
8.  Extraction buffer 1 (20uL/sample) 
- 5% Formic Acid in HPLC Water  
9. Extraction buffer 2 (20uL/sample) 
- -1:2 (v:v) 5% Formic Acid in HPLC Water : Acetonitrile 
Procedure:  Sample Preparation 
1. Grind decellularized lungs into a coarse powder using a mortar and pestle and 
liquid nitrogen 
2. Lyophilize and keep frozen at -20°C until further use 
3. Digest milled samples with pepsin in 0.1M HCl at a concentration of 10 mg ECM 
per 1 mL HCl. Pepsin (Sigma, St. Louis, MO) was used at a concentration of 1 
mg per mL. The ECM powder was digested for 65 hours and neutralized to a pH 
of 7.4 using 1 M NaOH (1 ml = 10 of original digest volume) and 10X PBS (1 ml 
=10 ml of final neutralized volume) 
4. Electrophorese solubilized ECM lung samples on a 4–20% precast linear gradient 
polyacrylamide under reducing conditions (5% 2-mercaptoethanol) for 20 minutes 
Procedure:  Sample Digestion 
1. Cut the spot and chop it with a clean razor blade into 1mm3 pieces. If 
Coomassie gel is used, cut spot as close as possible to minimize gel 
volume. 
2. Pick the gel pieces with the razor or with a wide bore P1000 tip or P1000 
tip with end cut off and put them in a 1.5mL microfuge tube 





Day 2   
1. Remove and discard Destain solution.  
2. Add 200uL of Acetonitrile to dehydrate. Gel pieces should turn white. If 
they do not, repeat Acetonitrile treatment. 
3. Remove and discard Acetonitrile solution.  
4. Air dry at room temperature until gel pieces no longer stick to the tube or 
each other. 
5. Add 100uL of 10mM DTT solution to reduce the gel. 
6. Incubate for 30min at room temperature. 
7. Remove and discard DTT solution. 
8. Add 100uL 50mM of Iodoacetamide solution to alkylate the gel 
9. Incubate for 30min at room temperature. 
10. Remove and discard Iodoacetamide solution. 
11. Wash with 200uL of 100mM Ammonium Bicarbonate solution. 
12. Incubate for 10min at room temperature. 
13. Remove and discard Ammonium Bicarbonate solution. 
14. Wash two times with 200uL of Acetonitrile solution to dehydrate the gel. 
Incubate each time for 5min at room temperature. Gel should turn white. 
15. Air dry at room temperature until gel pieces no longer stick to the tube or 
each other. 
16. Prepare Trypsin solution (See solution preparation for recipe). Choose 
either Dilution A or B based on amount of protein in gel band. 
17. Add 20uL of Trypsin solution to each spot (sample), keep cold until gel is 
rehydrated. If gel is not fully hydrated, add 20uL of Trypsin solution 
again. 
18. Incubate in ice for a few minutes. 
19. Add 20uL of 50mM Ammonium Bicarbonate solution to each spot 
(sample). 





(microfuge briefly before each solution transfer step) 
1. Add 20uL of Extraction Buffer 1 to each spot (sample) then vortex and 
centrifuge it. 
2. Transfer liquid to a new 0.5mL microfuge tube. 
3. Add 20uL of Extraction Buffer 2 to each spot (sample) then vortex and 
centrifuge it. 
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4. Transfer liquid to same new tubes as step 2. 
5. Store samples at 4oC if submitting directly to Analytical Core or at -20oC 
if leaving for more than 3-4 days. 
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Appendix E:  CD-31 Stained Explants 
Following subcutaneous implantation for four weeks, OA explants were sectioned 
and stained for presence of macrophages.  Unrelated to the immunogenicity experiment, 
these sections were also stained with CD-31 (green) and laminin (red) to visualize any 
presence of vascularization in allografts (top) and isografts (bottom).  These images 
demonstrate that vascularization occurred within the entirety of the scaffold—which was 





















Appendix F:  Regelled Decellularized ECM 
 Lung ECM decellularized using the OA procedure was subsequently regelled.  
The end product is an injectable gel that crosslinks at physiological temperature.  This 
technique could potentially be used in combination with our decellularized vascular 
tissue to fill the remaining space.  This tunable gel could potentially support adult or 
immature stem cells and direct differentiation using biochemical and mechanical cues. 
 
Procedure:  Sample Preparation 
1. Grind decellularized lungs into a coarse powder using a mortar and pestle and 
liquid nitrogen 
2. Lyophilize and keep frozen at -20°C until further use 
3. Digest milled samples with pepsin in 0.1M HCl at a concentration of 10 mg ECM 
per 1 mL HCl. Pepsin (Sigma, St. Louis, MO) was used at a concentration of 1 
mg per mL. The ECM powder was digested for 65 hours and neutralized to a pH 
of 7.4 using 1 M NaOH (1 ml = 10 of original digest volume) and 10X PBS (1 ml 
=10 ml of final neutralized volume) 
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